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Abstract 
With increased focus on host-microbe dynamics over the past decade, evidence that resident 
microbes affect host behaviour has mounted. Bacteria may be responsible for some of these 
effects as they produce a number of neuroactive compounds that could influence nervous 
system structure and function, leading to changes in behavioural phenotype. In the fresh 
water cnidarian Hydra, two behaviours are altered by microbiota: contraction frequency and 
feeding response duration. Here, I investigate the potential of resident microbiota to 
influence the structure and function of the nervous system in the early metazoan Hydra 
vulgaris AEP.  
I assess changes to nervous system structure by looking for altered neurogenesis and nerve 
cell density in adult polyps and find both unaltered in germ-free animals. This does not rule 
out the possibility of early-life alterations or smaller-scale changes to nervous system 
anatomy. Next, I present a metabolomics pipeline to aid in the identification of bacterially-
derived, contraction-regulating compounds. Future work in identifying these compounds can 
take advantage of the new extraction process detailed here, which can easily be reproduced 
from the isolated stocks of Hydra’s five main colonizing bacterial strains. 
I demonstrate the utility of the metabolomics pipeline in bioactive molecule identification by 
identifying a dipeptide potentially responsible for the increased chemotaxis of bacterial 
colonizers towards germ-free Hydra. This may be a new mechanism for host-led shaping of 
microbial community composition. 
Finally, I assess the potential role of Hydra microbiota in influencing nervous system function 
by searching for in vitro neurotransmitter production by Hydra-associated microbes and find 
that the microbial community produces gamma-aminobutyric acid (GABA). Metabolic 
modelling confirmed the presence of GABA-synthesizing enzymes in the genomes of all five 
main colonizers, though only Duganella seems to possess secretory ability via a GABA 
transporter. Both GABA and Hydra microbiota are reported to increase the duration of the 
feeding response, so microbial GABA production may play a role in increasing feeding 
response duration. As GABA feeds into central carbon metabolism, I further analyse the role 
of the Hydra metabolite and GABA precursor putrescine on the growth of the bacterial 
colonizers, and find all colonizers are able to grow in a medium that contains putrescine as a 
 7 
sole carbon and nitrogen source. This suggests that any microbial manipulation of behaviour 
via GABA is a by-product of core metabolic processes in the bacteria. The work presented 
here demonstrates the utility of untargeted metabolomics for approaching a mechanistic 
understanding of host-microbe interactions. 
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Zusammenfassung 
Mit zunehmender Forschung an Wirt-Mikroben-Interaktionen in den letzten Jahren zeigt sich 
mehr und mehr, dass Mikroben das Verhalten ihres Wirtes beeinflussen können. Bakterien 
produzieren eine Reihe neuroaktiver Verbindungen, die Einfluss auf Struktur und Funktion 
des Nervensystems haben und zu Änderungen im Verhalten führen können. Im 
Süßwasserpolypen Hydra werden zwei Verhalten durch die Mikrobiota verändert: die 
Kontraktionsfrequenz und die Dauer der Nahrungsaufnahme. In dieser Promotion untersuche 
ich das Potenzial der Mikrobiota die Struktur und Funktion des Nervensystems des frühen 
Metazoen-Hydra vulgaris AEP zu beeinflussen.  
Ich untersuche Veränderungen der Struktur des Nervensystems durch Analyse von 
Neurogenese und Nervenzelldichte in adulten Polypen, und finde beides unverändert in 
keimfreien im Vergleich zu konventionell angezogenen Tieren. Dies schließt kleinere 
anatomische Unterschiede oder Veränderungen zu früheren Zeitpunkten in der Entwicklung 
nicht aus.  
 
Als nächstes stelle ich eine Metabolomik-Pipeline vor, die bei der Identifizierung von 
bakteriellen, kontraktionsregulierenden Verbindungen helfen soll. Obwohl kein einzelnes 
Molekül für diese Verhalten verantwortlich zu sein scheint, zeige ich den Nutzen der Pipeline 
bei der Identifizierung bioaktiver Moleküle auf. Mithilfe der Pipeline konnte ich ein Dipeptid 
identifizieren, das möglicherweise für die erhöhte Chemotaxis von Bakterien in Richtung 
keimfreier Hydra verantwortlich ist. Dies könnte ein neuer Mechanismus für den Einfluss des 
Wirtes auf die Zusammensetzung der Mikrobiota sein. 
 
Zuletzt untersuche ich die potenzielle Rolle der Hydra-Mikrobiota im Einfluss auf das 
Nervensystems, indem ich die Neurotransmitterproduktion durch Hydra-assoziierte Bakterien 
in vitro quantifiziere. Dies zeigt, dass die Mikrobiota von Hydra den Neurotransmitter 
Gamma-Aminobuttersäure (GABA) produziert. Stoffwechselmodellierungen bestätigen GABA-
synthetisierende Enzymen in den Genomen aller fünf Hauptmitglieder der Mikrobiota, 
obwohl nur Duganella über einen GABA-Antiporter sekretionsfähig scheint. Da sowohl GABA 
als auch die Mikrobiota von Hydra Fressdauer des Polypenverlängern können, ist es möglich, 
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dass die die mikrobielle GABA-Produktion hier eine Rolle spielt. Da GABA Teil des zentralen 
Kohlenstoffmetabolismus ist, analysiere ich darüber hinaus die Rolle von Putrescin, einem 
GABA-Vorläufer und Teil des Metabolismus von Hydra, im Hinblick auf das Wachstum von 
Mikrobiotamitgliedern in vitro. Da alle untersuchten Bakterien in der Lage sind mit Putrescin 
als einziger Energiequelle zu wachsen, legt nahe, dass jede mikrobielle Manipulation des 
Verhaltens durch GABA ein Nebenprodukt der Kernstoffwechselprozesse der Bakterien ist. 
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Introduction 
Our understanding of host-microbe interactions has expanded greatly in the past decade, 
with an astonishing, and seemingly ever-mounting, array of aspects of host biology affected. 
From metabolism1 and fertility2, to pathogen defense3 and even behaviour4, the breadth of 
these effects is so vast that they call into question the very concept of self5. Reflecting this 
change in perception, the term “metaorganism” is often used in connection with host-
microbe interactions, defining the eukaryotic host within the context of its microbiota: the 
prokaryotes, unicellular eukaryotes, fungi and the viruses that reside in or on the host 
organism6. When considering the challenge that the metaorganism concept imparts on our 
concept of self5, one could argue that the influence that microbes appear to have on 
behaviour is of particular importance, for who are we if not the sum of our actions?  
The microbiome and nervous system anatomy 
Microbiota could induce structural changes to the nervous system by impacting neurogenesis 
and/or apoptosis rates, ultimately influencing neuronal density. Indeed, neurogenesis is 
regulated in part by brain-derived neurotrophic factor (BDNF), and BDNF expression levels are 
reduced in germ-free animals7. Similar to germ-free mice, chronically stressed mice have low 
levels of BDNF. Probiotic supplementation did not simply restore the expression levels of 
BDNF, but increased BDNF expression levels such that they were higher than expression levels 
in sham-treated control mice8. In the same study, probiotic treatment prevented stress-
induced decreases in hippocampal neurogenesis.  
Several research groups found an impact of the gut microbiota on adult hippocampal 
neurogenesis in mice, albeit the direction of the effect differed between the experiments.  
Möhle et al. uncovered a decrease in hippocampal neurogenesis in antibiotic-treated mice 
that could be corrected with probiotic supplementation9. Conversely, adult germ-free mice 
(germ-free from birth) have increased rates of hippocampal neurogenesis when compared to 
conventionally colonized mice4. The rate of neurogenesis was not restored to normal levels 
following recolonization of these germ-free animals, suggesting that microbial mediation of 
neurogenesis could occur during a critical period of development. In mammals, mediation of 
neurogenesis by the microbiome may occur through the vagus nerve, an important conduit 
through which the microbiota and brain are thought to communicate. It is a component of 
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the parasympathetic nervous system that influences immune responses, heart rate, digestion 
and mood10. Consistent with the findings of Ogbonnaya et al., mice with a severed vagus 
nerve had decreased rates of neurogenesis compared to control animals11. Accompanying 
neurogenesis changes were correlated with decreases in BDNF expression. Curiously, unlike 
the mouse study, vagotomy in rats did not result in altered neurogenesis12. 
Although the direction of the effect is unclear, host microbiota do appear to influence adult 
neurogenesis in mammals, and this could impact nerve-cell density. Assessing the ability of 
microbiota to mediate of nerve-cell density is important because certain cognitive diseases 
that are associated with dysbiosis, e.g. depression and autism13,14, are also associated with 
changes to nerve-cell density. 
The microbiome and nervous system function 
Another way in which microbiota impact the nervous system is through functional changes. 
For example, application of the bacterium Lactobacillus rhamnosus to the intestinal tract of 
germ-free mice increased the constitutive firing rate of the mesenteric nerve bundle (the 
mesenteric nerve bundle connects with the vagus nerve, an important conduit between 
bacteria, the gut and the brain)15. There are also a variety of studies that have demonstrated 
the production of various neurotransmitters by bacteria. These include gamma-aminobutyric 
acid (GABA), serotonin, dopamine and norepinephrine16,17. It is not clear whether or not the 
production of these compounds occurs at physiologically relevant amounts in vivo, however. 
Besides direct neurotransmitter production, bacteria can also influence the levels of host-
derived neurotransmitters; the production of colonic serotonin is stimulated by short chain 
fatty acids (SCFAs)18,19, for example. By inducing host serotonin release through SCFA 
production or other microbial metabolites (e.g. the tryptophan derivative tryptamine), 
microbes are able to indirectly increase neuron excitability20. Microbiota can also potentially 
influence the response of the host to its endogenous neurotransmitters by altering the 
expression of genes encoding neurotransmitter receptors, like dopamine21 or GABA 
receptors22. Considering the many ways in which microbiota influence the nervous system, it 
is perhaps not so surprising that a number of neurological disorders23,24 and mental illnesses25 
are associated with dysbiosis.  
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Microbes influence other nervous system outputs including gut motility 
Of course, the nervous system is responsible for much more than behaviour, and other 
nervous system outputs are also affected by microbiota. Gut motility in particular has 
received a lot of attention, likely due to the many lines of evidence connecting microbiota to 
irritable bowel diseases (Crohn’s disease and ulcerative colitis) and irritable bowel 
syndrome26–28; a hallmark of these is altered gut motility. Indeed, several bacterial 
metabolites affect gut motility, for example the SCFAs propionate and butyrate influence 
colonic motility. These metabolites are produced by bacteria in the gut as a by-product of 
dietary fibre fermentation29. Direct application of propionate to isolated guinea pig colon 
decreased colonic contractions, while butyrate increased them30. As mentioned above, 
bacteria can also induce the production of serotonin through SCFAs, which increases gut 
motility20. Bacterially-derived tryptamine can bind directly to serotonin receptors in the gut, 
impacting gastrointestinal motility by inducing fluid secretion31. 
Evolutionary perspectives on microbiota-nervous system interactions 
Eukaryotic life has always existed in the presence of prokaryotic life. Indeed, the existence of 
prokaryotes necessitated eukaryotic life, as the currently accepted theory of eukaryotic 
evolution states that the progenitor of the eukaryotic cell was itself a prokaryote that 
ingested another prokaryote, but rather than digesting it, formed a symbiotic relationship 
from which the entire domain Eukaryota would grow32,33. Since this pivotal moment, 
eukaryotic cells have existed alongside prokaryotic cells, providing ample time and 
opportunities for interdomain interactions to occur. 
 
In light of these longstanding interactions, along with observations that (1) host microbiota 
affect host fitness, (2) host microbiota can be transferred between generations, and (3) nearly 
every animal studied seems to form symbiotic relationships with some of its resident 
microbiota, the hologenome theory of evolution was proposed34. The holobiont refers to the 
animal host with its microbiota as a single unit, while the hologenome refers to the combined 
genomes within the holobiont. The hologenome theory of evolution posits that the holobiont 
can act as a unit of selection. This theory isn’t without its criticisms35, however, 
conceptualizing the hologenome as providing material upon which selection can act can be a 
useful framework to guide experimental design and interpretations36,37. 
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Certainly, when we consider the myriad of ways that microbiota interact with host nervous 
systems, it can be useful to keep this framework in mind, and it raises the question: have 
microbes been interacting with the nervous system since its very inception? Nervous systems 
help organisms to recognize and interact with their environments. Of course, microbes would 
be present in those environments and could have represented a friend or foe to even the 
earliest multicellular life. There is evidence to suggest that sponges (early metazoans of 
phylum Porifera) contain individual nervous system components and even have some 
contraction activities38,39, it is unclear to what extent sponge microbiota interact with these 
components. It is in phylum Cnidaria, sister clade to Bilateria, where we find a bona fide 
nervous system40 (Figure 1A). Within this phylum we have evidence of microbiota-nervous 
system interactions, suggesting that communications between microbiota and host nervous 
systems could be evolutionarily ancient interactions41–43.  
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Figure 1. (A) Cnidarians have the oldest extant nervous system among the eukaryotes. Note 
that the position of Ctenophora, which possess a nervous system vastly different than the 
eumetazoans, is currently debated44,45. (B) The Hydra nerve net. Sensory (S) and ganglion (G) 
neurons are marked with arrows. (C) Interstitial cells continuously give rise to neurons and 
other cell types in adult polyps. A,B: Adapted from Klimovich and Bosch (2018)43. C: Adapted 
from Boehm and Bosch (2012)46. 
Microbiota-nervous system interactions within the cnidarian Hydra vulgaris 
Within the phylum Cnidaria, the Hydra vulgaris AEP (hereafter Hydra) holobiont in particular 
has received a lot of attention. Despite the fact that Hydra has been cultured in the lab for 
over 40 years, its species-specific microbial community has remained surprisingly stable47,48. 
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Recent work in mice has demonstrated that the ancestral microbiome of mice (the microbiota 
of wild caught mice) provides a stronger fitness advantage than the microbial community of 
lab mice49. Because of the stability of the Hydra microbial community in the lab environment, 
Hydra can provide nuanced information about the effect of an evolutionarily-relevant 
microbial community on the nervous system. In fact, Hydra microbiota have protective effects 
against fungal pathogens3, and in the related species Hydra oligactis the microbiota have 
even been implicated in tumour formation50. The microbiota are also important mediators in 
feeding behaviour duration and contraction frequency of the polyps – both nerve cell-
dependent behaviours41,42. The mechanisms through which the microbiota interact with the 
Hydra nervous system is currently unclear. 
 
The nervous system of Hydra, like other cnidarians, is arranged in a nerve net (Figure 1B). 
Morphologically, there are two types of Hydra neurons, sensory and ganglion, and these were 
described over a century ago51,52.  The sensory neurons are exposed to the environment 
(either the gastric environment or the external environment, where direct contact with the 
microbiota is theoretically possible), while the ganglion neurons form the nerve net that 
stretches throughout the body53. These cells are produced continuously in adult polyps from 
multipotent stem cells called interstitial cells54 (Figure 1C). 
 
However, the simplicity evident under the microscope does not reflect reality at the 
molecular level. Recent work using single cell transcriptomics has successfully identified 
unique transcriptional signatures of at least 7 neuronal populations, suggesting that Hydra 
neurons may be specialized to a degree not previously appreciated55,56. Indeed, researchers 
have recently taken advantage of Hydra’s transparency to visualize its entire nervous system 
as it underwent a variety of behaviours and found that within the nerve net, there are several 
non-overlapping networks that control different aspects of behaviour53. 
 
As mentioned above, the spontaneous contractions of Hydra (Figure 2A) are mediated by 
Hydra microbiota41. Germ-free Hydra contract at roughly 60% the rate of control (i.e. 
microbe-containing) polyps. Recolonization of germ-free polyps increases, but does not fully 
restore, the contraction frequency (Figure 2B). Importantly, the increase in contraction 
frequency was observed when the germ-free polyps were reconventionalized with only the 
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five main colonizing bacterial species of Hydra, which make up the majority its species-
specific bacterial microbiome. Monocolonization of germ-free polyps with these five 
microbiota members was not enough to increase contractions to control levels (Figure 2C). 
However, one bacterial strain, Pelomonas sp. AEP2.2, was able to increase the contraction 
frequency relative to the germ-free polyps, suggesting that this strain may play a role in the 
mediation of contraction frequency. It is interesting to note that these experiments were 
performed on four-week starved animals and this could imply that there are structural 
changes to the nervous system that could not be repaired under nutrient limitation. Of 
course, it is also possible that the antibiotics used to render the animals germ-free was the 
damaging agent, or that the microbiome of the reconventionalized animals was not 
equivalent to the microbiome of control animals and this reconstituted microbiome was not 
as effective at controlling contractions than the microbiome of control animals. 
 
Finally, a third line of evidence suggests that Hydra microbiota may affect nervous system 
function. Cultivation of Hydra microbiota in vitro, and extraction of the secreted metabolites 
at either 24 or 48 hours and application these extracts to germ-free polyps was also able to 
increase contraction frequency (Figure 2D). Because these polyps were incubated with the 
extracts for only around 16 hours, it seems unlikely that the underlying nervous system 
structure was affected, and that these extracts worked by directly or indirectly affecting 
nervous system function. 
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Figure 2. (A) Longitudinal contractions of the Hydra body column. Treatment-naïve polyps 
contract on average 10.86±0.53 times per hour. (B) Antibiotic treated, germ-free polyps 
contract roughly 60% as often as control polyps. Colonizing germ-free polyps with 
microbiota from conventionally-raised polyps (Convent.) increased their contraction 
frequency relative to control polyps. Using a synthetic community of only the five main 
colonizing bacterial species of Hydra (5 bact.) likewise increased contraction frequency, but 
B C
A
D
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in neither case was contraction frequency fully restored. (C) Monocolonization of germ-free 
polyps with four of the five main colonizing bacterial strains of Hydra did not impact 
contraction frequency. The fifth strain tested, Pelomonas, was able to increase contractions 
relative to germ-free polyps. (D) Application of a microbe-conditioned medium increases 
contraction frequency of germ-free polyps. Two microbial extracts were created, with similar 
effects on contraction frequency: microbes were either cultured for 24 or 48 hours (M. ext. 
24h and M. ext. 48h, respectively). Figure adapted from Murillo-Rincon et al.41. 
Molecular aspects of Hydra contraction frequency and feeding response regulation 
The spontaneous contractions of the Hydra body column arise through the longitudinal 
contraction of the epithelial cells57. Thanks to a combination of single-cell transcriptomics, 
behavioural assays and in situ hybridization, we now know that the neuronal population 
controlling contraction behaviour sits just below the base of the tentacles. This population of 
nerve cells expresses nicotinic acetylcholine receptors, and three different ion channel-like 
transcripts (ANO1-, SCN-, and TRPM-like) that have been linked to gut motility or pacemaker 
cells in mammalian systems55. By interfering with these ion channels using inhibitors or 
activators of the channels, researchers were able to influence the contraction rate of the 
polyps. 
 
Other research groups have investigated the role of various small molecules on the 
contraction rate of Hydra and found that the amino acid/inhibitory neurotransmitter glycine 
decreases contractions, as does the non-proteinaceous amino acid taurine58. In the same 
study, the authors demonstrate a negative effect of the plant metabolite and toxin 
strychnine59 on contraction frequency, and conclude that these effects occur through the 
action of a strychnine-sensitive glycine receptor. It is worth noting that these chemicals also 
affect the duration of the feeding response in Hydra, another behaviour found to be 
influenced by Hydra microbiota. These chemicals increase the duration of the feeding 
response60, as does the presence of microbes in Hydra42. In that study, the authors also test 
the amino acid D-serine, and this had the opposite effect on the feeding response, decreasing 
duration. D-serine was not tested in the contraction study, so its effects on contraction 
frequency remain unknown. Another small molecule that interacts with the feeding and 
contractions of Hydra is the neurotransmitter GABA. GABA decreases contraction rates, while 
increasing the duration of the feeding response61.Taken together, these studies have an 
interesting implication. The small molecule studies suggest that the feeding response and 
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contractions are antagonistic, yet the microbiota of Hydra increase both feeding duration and 
contraction frequency. The implication, then, is that there are multiple neuroactive 
substances produced by Hydra’s microbial colonizers. 
Metabolomics as a way to identify microbially-produced compounds within the 
metaorganism 
Metabolomics seeks to identify all small molecules in an organism, tissue, or fluid. In practice, 
however, the picture is different: depending on the instrumentation and settings used, it is 
only possible to identify some fraction of the metabolites present in a given sample. 
Nevertheless, metabolomics has emerged as an important tool in biomarker discovery, and 
has been successfully applied to the study of host-microbe interactions62,63. It is possible, for 
example, to compare the metabolome of germ-free and conventionalized hosts and observe 
the effects of life without microbes on the metabolome62. Researchers have even induced 
mutations in microbial strains, allowed them to colonize a host, and were able to detect 
metabolic changes in the host63. Clearly, this can be a very powerful technique for 
determining the effect that resident microbiota have on their host species.  
The Hydra metaorganism is particularly well-suited for metabolomics research 
A major challenge in the field is pinpointing which metabolites are of microbial origin. 
Colonization of a host is likely to increase a whole suite of metabolites; some of these will be 
host-derived. Combining microbiome research with metabolomics in the Hydra 
metaorganism presents a unique opportunity in this regard: the main colonizers of Hydra are 
easily culturable, allowing for simultaneous investigation of main colonizer metabolomes and 
the metabolomes of microbe-containing and germ-free Hydra. The soft-bodied animals are 
easily homogenized, allowing for analysis of the entire organism’s metabolome. Thus, one 
could identify compounds high in microbe-containing animals relative to germ-free animals 
and look for evidence of bacterial origin by examining individual microbial metabolomes. 
Further, we know that the microbes are able to produce contraction-regulating compounds in 
vitro as the application of a microbial extract produced from in vitro cultured microbes 
increased contraction frequency. 
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Aims 
1. Develop a metabolomics pipeline for examination of the Hydra metabolome, and that 
of its resident microbes 
2. To identify potential contraction-mediating compounds produced by Hydra microbiota 
3. To search for evidence of microbial influence on nervous system function in Hydra by 
searching for microbially-produced neurotransmitters 
4. To look for evidence of structural changes to the nervous system elicited by the 
microbiome 
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Methods 
Generation and cultivation of germ-free and control polyps for BrdU labelling and 
behavioural assays 
Germ-free polyps were generated by a two-week incubation in an antibiotic mixture 
containing 50 μg/mL ampicillin, neomycin, rifampicin, and streptomycin, and 60 μg/mL 
spectinomycin. The control animals were incubated in 0.1% dimethyl sulfoxide as the germ-
free animals contain the same concentration owing to its addition in the rifampicin stock 
solutions41,64. Media were refreshed every other day. Polyps were allowed one-week recovery 
in sterile s-medium following antibiotic treatment. Routine checks for sterility followed the 
antibiotic treatment. This was accomplished by macerating a single polyp and plating the 
resultant liquid on R2A-agar (ROTH) and checking for signs of colony formation after 3 days 
incubation at room temperature. A final sterility check for non-culturable bacteria was done 
on the last day of treatment by isolating DNA from macerated polyps (DNeasy Blood & Tissue 
Kit, Qiagen) and confirming the absence of a 16S ribosomal RNA gene (hereafter 16S) PCR 
amplification product using the universal 16S eubacterial primer (F = 5’- 
CCTACGGGAGGCAGCAG-3’ and R = 5’- ATTACCGCGGCTGCTGGC-3’). 
Sterile feeding of Hydra 
Previous experiments comparing the contraction frequency of germ-free and control polyps 
were performed using Hydra that had been not fed for the entire 4-week duration of the 
antibiotic treatment and recovery period41. I reasoned that nutritional status may impact the 
extent of the differences observed between microbe-containing and microbe-free polyps. If 
the effect size was greater, then I could use less animals to detect differences between my 
treatments, increasing my capacity for extract testing. To test this, I used fed, long-term 
germ-free and control polyps that were kindly supplied by my colleague, Jinru He.  
 
His protocol for feeding of these polyps using germ-free Artemia salina nauplii was as follows: 
commercial Artemia cysts (Ocean Nutrition) were Hydrated with sterile Milli-Q water for one 
hour with aeration and decapsulated by a 10 minute incubation on ice with 1:1 (v/v) diluted 
12% sodium hypochlorite solution (Roth)65. Cysts hatched overnight in 2.5% (w/v) antibiotic-
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treated sterile artificial seawater (350 rpm at 30⁰C). Following hatching, Artemia larvae were 
incubated in the antibiotic cocktail for four days with daily medium replacement, followed by 
a two-day incubation period in antibiotic-free sterile artificial seawater.  
 
Hydra were fed every two days and maintained under sterile conditions in antibiotic-free 
media for a total of 30 weeks. Sterility of both Hydra and Artemia were confirmed by the 
absence of bacterial colonies on R2A-agar and a lack of 16S PCR amplification products, as 
described above.  
Neurogenesis and neuronal density assessment 
To look for changes in neurogenesis I used the thymidine analogue 5-bromo-2-deoxyuridine 
(BrdU), which labels dividing cells through incorporation of BrdU into growing DNA strands66. 
Neuronal density was assessed by counting the ratio of neurons to epithelial cells. I used 
starved animals (given one-week recovery following two-week antibiotic treatment) (n = 50 
germ-free and 50 control polyps; 3 replicates) and well-fed animals from the long-term germ-
free culture (n = 20 germ-free, 20 recolonized, and 20 control polyps; 2 replicates). I 
incubated polyps in sterile s-medium containing 2 mM bromodeoxyuridine (BrdU) and 
changed the medium every 12 hours, for a total of 72 hours incubation time. At 72 hours, I 
macerated the animals and mounted them on gelatine-covered slides for visualization of 
BrdU by immunohistochemical labelling67. To achieve sufficient cell densities, 8 starved 
polyps, or 1-2 fed polyps were macerated onto a single slide. Immunodetection of BrdU was 
performed as described previously68. To assess the differences in labelling and nerve cell 
density of starved germ-free and control polyps, I used Welch’s t-test (GraphPad Prism 4). For 
fed control, recolonized, and germ-free animals, I used an analysis of variance (ANOVA) 
(GraphPad Prism 4). Data are expressed as means ± SEM (standard error of the mean).  
Preparation of original bioactive extracts for solid phase metabolite extraction 
A small amount of the original contraction-mediating extracts used in the Murillo-Rincon 
paper41 were left over and were provided by Dr. Murillo-Rincon so that I could reveal their 
metabolic contents via mass spectrometry. The full methods are detailed in the paper, but 
briefly, these two extracts were prepared by inoculating an R2A-agar plate with three 
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homogenized Hydra polyps and grown for three days at 18°C before a final incubation for 
either 24- or 48 hours in s-medium. The microbially-conditioned media were concentrated 
through a solid phase extraction (SPE) using a C18 column. In the final step of the SPE, the 
metabolites were released from the column using methanol. This methanol was evaporated 
before they were resuspended in s-medium.  
 
The overall concentration of salt in s-medium is low, but my preliminary experiments 
indicated that these salts may interfere with signal acquisition, so I desalted the samples using 
a standard C18 SPE (described below). To prepare the two extracts for the C18 extractions, 
the volume of samples available (approximately 500 µL) were acidified using 1 mL 0.12 N HCl 
in ultrapure water. 
Preparation of germ-free and control Hydra for solid phase metabolite extraction 
Germ-free and control Hydra were cultured according to the study by Murillo-Rincon41 using 
two weeks antibiotic treatment and two weeks recovery time in sterile s-medium. Fifty total 
polyps were used per replicate, with a total of five replicates per treatment. During the 
routine sterility assessment (described above) one germ-free replicate was found to be 
contaminated and removed from further processing. 
 
On the thirteenth day of recovery in sterile s-medium, the Hydra polyps were washed and 
checked for sterility a final time before resuspension in 25 mL sterile s-medium. One day 
later, the tubes were immersed in liquid nitrogen until completely frozen and lyophilized 
(CHRIST Alpha 2-4 LSC) for 48 hours to dryness. These dried samples were resuspended in 1 
mL pure methanol (LiChrosolv® grade, Merck) sonicated for 20 seconds and homogenized by 
bead-beating in a pre-cooled Precellys homogenizer (5,800 RPM, 2x15 seconds, with 30 
second pause). The resultant homogenate was centrifuged at 10,000 x g for 10 minutes at 
20°C. The methanol was evaporated using a vacuum centrifuge at 8 mBar for one hour (40°C). 
Finally, the metabolites were resuspended in 1 mL acidified water (0.12 N HCl in ultrapure 
water). 
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16S PCR sequencing and analysis of control animals used for metabolomics analysis 
DNA was isolated from each of the 5 control replicates for 16S sequence analysis. Sequencing 
was performed by the Institut für Klinische Molekularbiologie (IKMB) on the Illumina MiSeq 
platform. I annotated the sequences using QIIME 1.9.169, and used BioEdit 7.270 to search the 
resultant operational taxonomic units (OTUs) for the main colonizing species of Hydra, based 
on the reference 16S sequences found in the Compagen database71. 
In vitro cultivation and preparation of Hydra bacterial colonizers for solid phase 
metabolite extraction 
R2A broth was inoculated with each of the five main colonizing bacterial strains of Hydra  
(Undibacterium sp. C1.1, Pelomonas sp. AEP2.2, Duganella sp. C1.2, Curvibacter sp. AEP1.3, 
Acidovorax sp. AEP1.4 – hereafter referred to by genus names only) and incubated for 2 days 
at 18°C (250 rpm). Each of these strains has a different growth rate in R2A, so I used the 
growth rate information supplied by Dr. Peter Deines to stagger the inoculation times such 
that all strains hit early stationary phase at the same time. By diluting the starter cultures to 
an OD600 of 0.1 and inoculating 10 mL of culture, I could assume that Undibacterium, 
Pelomonas, Duganella, Curvibacter, and Acidovorax would take 30, 27, 23, 33, and 25 
hours to hit stationary phase, respectively. 
 
R2A is a complex, chemically undefined medium and it needed to be removed lest it interfere 
with mass spectrometry data acquisition and analysis. To accomplish this, I centrifuged all 
cultures at 4,600 rpm for 25 minutes (4°C). I washed the remaining R2A away by 
resuspending the resultant pellet in sterile s-medium (a chemically defined medium used for 
standard culturing of Hydra with no carbon, nitrogen or phosphate source) and centrifuging a 
second time. I then discarded this s-medium and weighed the cell pellets in order to 
standardize the biomass in each culture. To create a co-culture of the main colonizers, I 
aliquoted 1.4 mL from each of these biomass-equilibrated cultures into a single test tube for a 
total of 7 mL cell suspension. For the individual strains, 7 mL of the biomass-adjusted cultures 
was used. All of these cultures were incubated for 24-hours at 18°C (250 rpm).  
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To quench the metabolism of the cultures quickly, I added 7 mL pure, cold (-80°C) methanol 
and froze the samples at -80°C until they could be transported on dry ice and further 
processed at the mass spectrometry lab in Munich. 
 
Upon arrival in Munich, bacterial cells were immersed in an ultrasonic water bath for 30 
minutes to release intracellular metabolites, and the cell fragments were removed by 
centrifugation at 10,000 x g for 10 minutes (4°C). 1 mL of this supernatant was removed, and 
the samples were dried for 5.25 hours at 8 mBar (40°C) in a vacuum centrifuge (Eppendorf 
Concentrator Plus). The metabolites were resuspended in 1 mL acidified water (0.12 N HCl in 
ultrapure water).  
Solid phase extraction of metabolites from extracts, Hydra and bacteria 
Ultimately, the Hydra, the in vitro bacterial samples, and the original bioactive extracts would 
be compared in their metabolite content. This required the same solid phase extraction 
protocol to ensure similar eluting conditions between experiments.  
 
A fresh C18 column (50 mg sorbent, 1 mL capacity, Agilent Bond Elut) was loaded onto a 
vacuum manifold system (Standard 24-port, 57 250-U, Sigma-A) connected to a pump system 
(Vantage 3000 C S 10, Svenska Pump AB) at a flow rate of approximately 20 mL min−1. The 
column was first washed with 1 mL 100% methanol (LiChrosolv® grade, Merck), and then 
conditioned with 1 mL acidified water (0.12 N HCl in MilliQ water), before the 1 – 1.5 mL 
acidified sample was loaded. The column was washed with 3 mL 0.12 N HCl before the 
samples were eluted in 1 mL pure methanol.  
Mass spectrometric analysis of the Hydra, in vitro bacterial samples and original 
extracts 
These samples were analysed on a Bruker SolariX 12 Tesla Fourier transform ion cyclotron 
resonance mass spectrometer (FTICR-MS). The samples did not require dilution prior to 
analysis. Spectra were acquired in negative ionization mode with a scanning range between a 
mass-to-charge ratio (m/z) of 147 to 1000. 
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Preprocessing of mass spectrometry data from Hydra, in vitro bacterial samples and 
original extracts 
Preprocessing of metabolomics data is an important step that helps select true metabolites 
from among the noise that accompanies high-resolution mass spectrometry data and results 
in a table of aligned peak and intensity information72. This step is required for comparison of 
spectra across samples. 
 
The first step in preprocessing is spectrum calibration. This step corrects for the small 
differences in mass traces from their expected values. Here, I used Bruker Compass 
DataAnalysis software for internal spectrum calibration. The calibration lists contain mass 
traces of various molecular weights across the scanning range, so that they can be identified 
within the mass spectra of the samples and the spectra can be shifted accordingly. The 
internal calibration file used for calibration was designed by Jenny Uhl (Helmholtz Munich) 
and contained Hydra-specific mass traces (Supplementary Table 1). This file was used to 
linearly calibrate the spectra with a maximum mass difference of 1 ppm (part per million). The 
mass lists are exported individually, and the peaks aligned with an error window of 1 ppm 
using Matrix Generator 0.4.  
Statistical analysis of mass spectrometry data from Hydra, in vitro bacterial samples 
and original extracts 
My preprocessing strategy produced a large matrix containing peak list information from the 
three experiments. The goal here was to find mass traces high in control polyps that were also 
present in the bioactive extracts and produced by Pelomonas and/or in the co-cultured 
bacterial samples. Structural differences in the datasets prevented further processing using 
the entire matrix file, so the experiments were separated. 
Statistical analysis of metabolomics data from germ-free and control Hydra 
To find mass traces high in control relative to germ-free samples, I applied the “modified 80% 
rule”73 as a first step in addressing the missing values in the dataset. A standard 80% rule 
would require 80% or more of the intensity values for a given mass trace to be above zero. 
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The modified 80% rule includes class information as well – mass traces must be above zero in 
at least 80% of the replicates for at least one treatment.  
 
Further processing was done using Metaboanalyst 4.074. Remaining zeroes were replaced 
with half of the minimum positive value in the dataset, under the assumption that 
compounds corresponding to these mass traces were below the limit of detection. To ensure 
a Gaussian distribution, data were log normalized and auto-scaled (mean-centred and divided 
by the standard deviation of each variable). A t-test combined with fold-change analysis was 
used to determine which mass traces has significantly different intensity values (fold change > 
1.5, praw < 0.05). Data were visualized using a principal component analysis (PCA) and a 
heatmap. 
Statistical analysis of metabolomics data from liquid-cultured bacteria 
For the bacterial dataset, the “modified 80% rule”75 was applied before upload to 
Metaboanalyst 4.074, where remaining missing values were replaced by a half of the minimum 
positive value in the dataset. Similar to the Hydra dataset, the data were log transformed and 
auto-scaled. Statistical differences in mass traces were identified using ANOVA with a Fisher’s 
least significant difference post hoc test (significance threshold p > 0.05). Data were visualized 
with a PCA and heatmap. 
Searching for overlap between the datasets 
I created a relational database to check for overlaps in the output of the three experiments 
using SQL (Structured Query Language) and looked for three types of overlap: (1) mass traces 
high in Hydra, and present in both the bioactive extracts and in at least one liquid bacterial 
culture, (2) mass traces high in Hydra and present in the extracts, and (3) mass traces 
common between the extracts and present in at least one liquid bacterial culture. 
From mass trace to compound name: metabolite annotation 
To putatively annotate the m/z list, I used the CEU Mass Mediator 3.0 tool76 to simultaneously 
search the KEGG77, LipidMaps78, and Human Metabolome Database (HMDB)79, and Metlin80 
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databases (using an error window of 1 ppm). To account for the possible formation of 
adducts, the compound annotations included the following possible adducts: M+H, M+Cl, 
M+FA+H, and M-H+H2O. Peptides were also included in the annotation results.  
Cultivation of bacteria for new extracts used in both behavioural assays and mass 
spectrometry analysis 
My extraction methods were based on that developed by Dr. Murillo-Rincon41. I modified the 
basic protocol to create three different bacterial extracts for contraction testing (Figure 3A). 
The original method utilized three Hydra polyps, washed with sterile s-medium and 
homogenized in a microcentrifuge tube using a microcentrifuge pestle as the inoculum for 
bacterial culturing on R2A-agar plates. The bacteria were then cultured for 3 days at 18°C, 
and the colonies were gently removed using 3 mL sterile s-medium and water. This cell 
concentrate was then added to 400 mL sterile s-medium and allowed to incubate for 24 
hours at 18°C (250 rpm). 
 
I also created a vehicle control extract to test the effect of the low levels of R2A that might be 
carried over using this protocol. This extract was made in the same way as the microbial 
extract, except I washed an empty R2A-agar plate with 3 mL sterile s-medium and 
“inoculated” this into 400 mL s-medium (Figure 3B). After a 24-hour incubation, I plated 1 mL 
of the suspension on R2A-agar to check for contamination. 
 
Finally, I created an extract that did not require microbes to be acquired directly from the 
host. Because previous extracts utilized the microbiota from three single polyps, I used three-
fold the reported carrying capacity of a single Hydra polyp3. I cultured each of the five main 
colonizing species of Hydra independently in liquid R2A medium (LAB) at 18°C (250 rpm). 
These starter cultures were diluted to equal colony forming units per mL and inoculated onto 
R2A-agar using the same steps outlined above (Figure 3C). 
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Figure 3. Three extraction protocols were utilized in this report. The first (a) was created 
according to Murillo-Rincon et al.41. The second was a microbe-free control (b), while the 
third (c) utilized the five main colonizing species, plated at equal colony forming units per 
millilitre to create a more reproducible assay. C18 = C18 SPE column; MeOH = Methanol. 
 
Solid phase extraction of bacterial metabolites for behavioural assays 
Following the 24-hour incubation in s-medium, the media need to be concentrated, and the 
cells removed. To accomplish this, I employed an SPE. I centrifuged the cells (4250 x g for 15 
minutes at 4°C), reserving two 100 µL aliquots of the resultant pellet for 16S analysis, and 
filtered them using a 0.2 µm filter. Sequence acquisition and analysis was performed as stated 
above.  
 
For the SPE, I used an C18 column (Supelco Supelclean 60 mL), prepared by washing the 
column in 50 mL methanol (UPLC-grade, Sigma), followed by column conditioning with 50 mL 
MilliQ water. I then add the bacterially-conditioned medium (400 mL), and washed the 
column using 150 mL MilliQ water. I used pure methanol (UPLC grade, Sigma) to elute the 
metabolites. I reserved 1 mL of the eluant and stored it at -80°C until mass spectrometry 
analysis. To test the extracts on Hydra, the methanol needs to be removed. I used 
lyophilization for this step. Because of methanol’s extremely low freezing point, I needed to 
decrease the concentration of methanol to 40% before drying completely (ca. 24 hours) in a 
freeze dryer (CHRIST Alpha 2-4 LSC). 
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Behavioural assays 
The protocol for behavioural assays was based on the original protocol described by Dr. 
Murillo-Rincon41. The germ-free and control animals were washed a final time in s-medium 
before being incubated overnight at 18°C in s-medium or s-medium plus bacterial extract 
(diluted 1:25). To ensure the animals were light-adapted, the light remained on during this 
incubation period. The following day, the polyps were arranged under a dissecting 
microscope (M3C Wild Heerbrugg) in a concave glass slide containing approximately 0.5 mL s-
medium (and extract, when used). Each slide contained a single polyp, which was recorded 
using a digital camera (Breukhoven Microscopes Systems). The live images from the camera 
were captured using Chronolapse software set to take a screen capture every 3 seconds. Each 
polyp was recorded for a total of 80 minutes, with the first 20 minutes discarded as the 
acclimatization period. The series of jpeg screen shots were processed by ImageJ to produce a 
video, which was used to count the contractions during the hour-long recording window. 
Statistical analysis and visualization of behavioural assays 
Statistical analysis and graphics were created using R and the ggplot2 and yarrr packages81–83. 
The initial R script was kindly supplied by Dr. Murillo-Rincon and I made changes where 
appropriate for my own data structure. I converted the number of contractions per hour to 
the percentage of the mean control value, checked to make sure the data were normally 
distributed (packages Car and MASS)84,85 and assessed the differences in contractions via a 
Welch’s t-test. Each individual polyp was considered a single replicate. 
Mass spectrometry analysis of the new five-microbe bacterial extracts 
After observing that the five-microbe extract increased contraction frequency, I scaled this 
experiment up to include three microbe-containing extracts and three microbe-containing 
controls, which were all resuspended in MilliQ water rather than s-medium so I could avoid a 
second C18 extraction and concentrate the samples, if needed. With this amendment to the 
protocol I was able to run the six samples directly on the mass spectrometer. 
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The scanning range of m/z 147 – 1000 utilized in the above listed mass spectrometry 
experiment did not provide strong candidate molecules for behavioural testing. I reasoned 
this may be a result of the scanning window, as many bioactive molecules have molecular 
masses outside of this range. To address this, these samples were run on an FTICR-MS at Kiel 
University (7 Tesla, SolariXR) that offers greater flexibility in scanning range. Samples were run 
in both positive and negative ionization mode with a scanning range between m/z 65 - 950. 
Preprocessing of the five-microbe bacterial extracts mass spectra 
To calibrate the mass spectra, I used MetaboScape 4.0 (Bruker). The data were calibrated 
linearly using an internal mass list with a calibration tolerance of 1 mDa and an intensity 
threshold of 106. Mass traces were only included in downstream analyses if they were 
present in at least 2 of the 6 samples. Peak annotation was performed using an in-house mass 
list specific for neurotransmitters.  
Statistical analysis of the five-microbe bacterial extracts mass spectra 
For further processing, mass traces needed to be present in at least two of the three 
replicates in at least one treatment (microbe versus R2A control). The raw spectra were 
uploaded to Metaboscape 4.0. in MRMS single spectra mode. Linear calibration was used 
using internal calibration lists with a tolerance of 1.00 mDa and an intensity threshold of 106. 
Mass features were annotated using a neurotransmitter-specific annotation list. The mass 
lists were processed using Metaboanalyst with the same normalization techniques used 
previously (log normalization and auto-scaling). To identify significant differences, a t-test was 
combined with a fold-change analysis (p < 0.05, FC > 1.5) and these traces were visualized 
using GraphPad Prism. 
Metabolic modelling of GABA metabolism in Hydra’s main colonizers 
Metabolic models for GABA metabolism were generated by Georgios Marinos (Institute of 
Experimental Medicine, University Medical Center Schleswig-Holstein). Briefly, the metabolic 
models were created using the draft genomes of Curvibacter, Undibacterium, Pelomonas, 
Duganella, and Acidovorax. The nutritional environment used for modelling was based off of 
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the nutritional profile of R2A and included a small quantity of GABA (10-6 mM) because 
preliminary experiments detected a small amount of GABA in uninoculated medium and 
because it was important to ensure GABA was available for exchange reactions. The models 
were created using GapSeq (development version 3185ca1) and run using R and the package 
sybil86.  
Bacterial growth on putrescine as a sole carbon and nitrogen source 
I grew each of the main colonizing species for two days in 3 g/L of the complex medium R2A 
at 18°C (250 RPM). Then, I washed these starter cultures twice in s-medium by centrifuging at 
3,000 x g (10 min at 4°C), removing the supernatant, adding an equal volume of s-medium, 
vortexing 30 seconds and repeating. Next, I inoculated the clean cultures with a 1:50 dilution 
into s-medium with putrescine (Sigma) at final concentrations of 0, 1, and 10 mM, or into R2A 
as a positive growth control. Growth was assessed on a 96-well plate by recording the OD600 
of each culture (Tecan Spark 10M) at intervals of 15 minutes for a total of 23 hours (18°C). 
Data visualization and statistical analysis 
I used an R script to visualize the bacterial growth curves based off of the one published by 
Brian Connolly87. This code uses the R core functions and the packages reshape2, dplyr, 
ggplot2 and gtable81,82,88–90. I used the package growthcurver91 to obtain the maximum 
carrying capacity of the different media types so that I could perform statistical analysis using 
R core functions (analysis of variance with Holm-Bonferroni post-hoc analysis)81. Note that 
the cultures did not reach stationary phase, thus the carrying capacity in these cultures was 
not reached and the maximum density is simply used as a proxy for biomass accumulation. 
Searching mass spectrometry data for bioactive compounds influencing bacterial 
chemotaxis 
The data processing pipeline I developed to search for a bacterially-derived, contraction-
regulating molecule could be modified to search for common compounds between Hydra and 
its bacterial colonizers. There are 67 mass traces that overlap between these two mass 
spectrometry datasets (these compounds were significantly increased or decreased in control 
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polyps relative to germ-fee polyps). New work from Dr. Peter Deines revealed increased 
chemotaxis-eliciting effects of germ-free Hydra relative to control Hydra92. I searched the list 
of compound annotations for known chemotaxis-eliciting compounds that might be 
responsible and found a compound (m/z 227.1401) that corresponded to a chemotaxis-
eliciting dipeptide. The intensities of this mass trace were analysed and visualized using 
GraphPad Prism 5.0.  
Prediction of secondary metabolites based on the genomes of the main colonizers 
Having a list of the metabolic potential of the bacteria could be useful in compound 
identification. Therefore, I used antiSMASH93 (Antibiotics and Secondary Metabolite Analysis 
Shell) to search the draft genomes of the main colonizing strains to search for potentially 
bioactive secondary metabolites.  
MS/MS to confirm the identity of the dipeptide 
To confirm the identity of m/z 227.1401, I cultured Curvibacter, Duganella, Acidovorax, 
Undibacterium and Pelomonas as previously described. I amended the metabolism quenching 
step to improve efficiency by simply centrifuging the samples following their 24-hour 
incubation in s-medium (3000 x g, 10 minutes, 4°C), and dropping them directly in liquid 
nitrogen. The samples were then loaded on the 7 Tesla SolariXR FTICR-MS in flow injection 
mode with an injection volume of 60 µL. Ionization was done in both positive and negative 
mode. To fragment the target ion, we chose the sample with the highest concentration of the 
target (Undibacterium) for MS/MS fragmentation. 
 
To increase the total concentration of the 227.1401 target ion further, I grew the bacterial 
strain as before but did not dilute the culture before metabolic quenching. The sample was 
loaded with the four possible dipeptide isomers prolyl-leucine (Sigma), leucyl-proline (Sigma), 
isoleucyl-proline (Bachem), and prolyl-isoleucine (Bachem) at 1 nM concentrations. Using 
DataAnalysis (Bruker), I searched the spectra for the expected fragmentation patterns of the 
dipeptides that are published in the HMDB94 and Metlin80 databases. 
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Results 
Microbiota do not influence neurogenesis or nerve cell density in adult polyps 
To assess microbial influences on neurogenesis, fed and starved Hydra (with and without 
microbes) were incubated in BrdU-containing s-medium for 72 hours. The proportion of 
unlabelled:labelled cells  was counted and is reported here as the labelling index (in percent). 
After 72-hours continuous labelling, no differences could be detected in either starved 
(control: 23.1 ± 2.5%, n = 9; germ-free: 22.3 ± 3.2%, n = 13; p = 0.79; Figure 4B,C), or fed 
polyps (control: 28.3 ± 4.8%, n = 7; germ-free: 29.3 ± 2.8%, n = 7; recolonized: 31.4 ± 3.4%, n 
= 7; p = 0.84) (Figure 5B,C). 
 
In the absence of an altered rate of neurogenesis in germ-free animals, changes to the 
density of the nerve net, as measured by an increase of the nerve cell to epithelial cell ratio, 
were still possible. No such changes to neuronal density were observed in starved (control: 
0.29 ± 0.035, n = 6; germ-free: 0.34 ± 0.02, n = 7; p = 0.23; Figure 4C) or fed polyps (control: 
0.19 ± 0.012, n = 15; germ-free: 0.21 ± 0.011, n = 14; recolonized: 0.20 ± 0.014, n = 13; p = 
0.72) (Figure 5C). 
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Figure 4. The BrdU labelling index of the neurons of starved control polyps and that of 
starved germ-free polyps did not vary significantly after 72 hours continuous labelling. (A) 
Culturing and antibiotic treatment scheme. (B) The labelling index of neurons from control 
and germ-free individuals was not different (C) The nerve cell density was similarly 
unaffected in starved animals. 
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Figure 5. Nerve cell density and neurogenesis are not impacted by the Hydra microbiome in 
long-term, fed polyps. (A) Antibiotic treatment, culturing protocol and feeding schedule for 
the long-term germ-free polyps. (B) No difference in neurogenesis between control, 
recolonized, or germ-free polyps (p = 0.84) was observed. (C) The neuronal density in these 
animals was similarly unaffected (p = 0.72). 
 
16S analysis of germ-free and control Hydra polyps used for metabolomics analysis 
16S analysis of the native bacteria of Hydra indicated that one of the five control animals had 
a high relative abundance of the spirochaete Turneriella sp. The relative abundance of 
Turneriella sp. in this sample was 36.4%, while the other four samples had abundances 
between 0 and 0.1% (Supplementary Table 2). This sample did not contain any members of 
phylum Bacteroidetes, despite a total average abundance between 5.2 and 29.2% in the 
other four samples. The remaining four samples were much more homogeneous in their 
microbial composition (Figure 6), so the Turneriella-containing sample was excluded from 
metabolomics analysis. One germ-free sample was similarly excluded because, despite a lack 
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of colony growth on R2A-agar, there was successful amplification of 16S DNA in the polyp, 
indicating that the sample may have been contaminated.  
 
 
 
 
Figure 6.16S sequence analysis resolved at the level of phyla. Each bar represents a single 
sample. Replicate one (far left) contains a high abundance of Spirochaetes and is devoid of 
Bacteroidetes so it was excluded from further analysis.  
 
 
Metabolomic analysis of germ-free and control Hydra 
To understand what compound(s) were influencing contraction frequency in Hydra, I looked 
for mass traces that were common between microbe-containing Hydra, in vitro cultured 
Hydra colonizers, and the original bioactive extracts. This required three separate untargeted 
mass spectrometry experiments. In the first, I examined the metabolomes of germ-free and 
control Hydra to find mass traces that might represent bacterially-derived compounds. 
Compounds high in control Hydra (FC > 1.5, p < 0.05) were flagged as potentially microbially-
derived and proceeded through my data processing pipeline. 
 
The raw mass spectra of the Hydra samples contained 4619 unique mass traces. Many of 
these are artefacts and need to be removed before biological interpretation can be 
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accomplished. I used the modified 80% rule73 (technically 75% since there were only four 
samples per replicate) to reduce Hydra-specific mass list to 3084 mass traces. Differences in 
the metabolite profiles between germ-free and control animals are visible in both the PCA 
plot and heatmaps (Figure 7Figure 8). There were 149 compounds high in control polyps 
relative to germ-free polyps and 196 low in controls relative to the germ-free polyps (FC > 1.5, 
p < 0.05). 
 
 
 
Figure 7. PCA plot of the germ-free and control Hydra metabolomics data. Each point 
represents a single replicate containing 50 polyps each.  
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Figure 8. Heatmap showing the top 100 mass traces altered between germ-free and control 
polyps. The samples and mass traces were clustered hierarchically using a Ward’s linkage 
algorithm with Euclidean distances. Each sample is represented as a single column, with 
germ-fee animals in green and control animals in red. 
 
 
 
127 mass traces were significantly altered (FC > 1.5, p < 0.05; Figure 9) and I was able to 
annotate 88 of these with putative compound names, though many mass traces have hits to 
multiple compounds due to the presence of isomers or adducts, so there are a total of 1538 
annotations for the 88 mass traces (Supplementary File 1).  
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Figure 9. A volcano plot indicating significantly altered mass traces between germ-free and 
control polyps. Each point represents a single mass trace, with significantly altered traces in 
pink (FC > 1.5, p < 0.05). Mass traces high in control animals have positive fold change values 
(log2(FC)), while masses high in germ-free animals have negative fold change values. 
 
Metabolomic analysis of in vitro bacterial samples 
In the next mass spectrometry experiment, I examined the metabolomic profiles of the five 
main colonizers. Recolonization of germ-free Hydra with Pelomonas or all five main colonizers 
was enough to increase contraction frequency of control polyps41. Because the bioactive 
extracts were produced in vitro, I reasoned that Pelomonas and/or co-cultured main 
colonizers would produce contraction mediating compound(s) in vitro. 
 
Following application of the modified 80% rule to remove problematic zero values from the 
bacterial mass spectra 1369 mass traces remained. Because I couldn’t be sure that the mass 
trace(s) representing contraction-mediating compounds would be significantly different 
under my culturing conditions, the entire list of 1369 compounds was used to look for mass 
traces shared between this and the Hydra and original extracts datasets. 
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PCA plots indicate stark differences between the metabolite profiles of Undibacterium and 
Curvibacter relative to the other strains and the co-cultured strains (Figure 10). This is also 
evident in the heatmap, where one can see many Curvibacter and Undibacterium-specific 
mass traces (Figure 11). Fisher’s Least Significant Difference post-hoc test identified 1039 
mass traces as significantly altered across the strains (Supplementary File 2). 
 
Figure 10. PCA plot of MS data from the main colonizers of Hydra. Each point represents an 
individual replicate, with the colours representing the strains and co-culture.  
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Figure 11. Heatmap depicting the relative intensities of the mass traces in the metabolic 
profiles of the five main colonizers of Hydra (alone and in co-culture).Each column 
represents a single sample, while the coloured bars represent the strains (Undibacterium: 
yellow, Curvibacter: dark blue, Acidovorax: red, Duganella: light blue, Pelomonas: purple, co-
culture: green). 
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Metabolomic analysis of original extracts  
Finally, in the third mass spectrometry experiment for the bioactive-compound-identification 
metabolomics pipeline, I examine the metabolomic profiles of the original bioactive extracts 
(these samples were used in the assays for the original report41). 16,063 mass traces were 
identified in the two original extracts, and 1188 of these were identified in both extracts. With 
only two replicates, this dataset did not lend itself well to statistical analysis, so all of the mass 
traces were included in the subsequent analyses in this pipeline. 
Overlap between datasets 
Finally, with these three experiments, I was able to create a data processing pipeline to look 
for compounds that might increase contraction frequency. I looked for mass traces common 
to control Hydra, the in vitro-cultivated microbes and the original extracts. Six mass traces 
meet these criteria (Supplementary Table 3) and I found annotations for 4 of the 6 mass 
traces. Due to the presence of isomers or adducts, these 4 mass traces match the expected 
m/z of 31 compounds (Supplementary Table 4, Supplementary File 3). One mass, 365.1373, 
matched with 17 compounds. 
 
Of course, it is possible that the contraction-regulating compound(s) are quickly turned over 
in vivo or not produced at sufficient amounts to be detected by the mass spectrometer. To 
account for this, I also looked for compounds common between the extract and microbial 
datasets. 144 additional compounds were common between the datasets with annotations 
possible for 115 of the mass traces. The mass traces match the expected m/z of 1818 
annotations (Supplementary Table 3, Supplementary File 4). 
 
Further, I had to consider the possibility that the target compound(s) were not produced or 
not detected under the bacterial culturing conditions. In that case, compounds present in 
both the extracts and high in microbe-containing polyps are of interest. An additional 3 
compounds that were high in control animals were also present in the extracts, but not in the 
microbial dataset (Supplementary Table 3, Supplementary File 5). Annotations were possible 
for all three of the mass traces, for a total of 13 annotations. 
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Germ-free Hydra polyps contract less frequently than control animals 
The original behavioural assays that demonstrated the effect of Hydra microbiota on 
contraction frequency were performed on starved polyps41. I assessed the differences in 
contraction rate between germ-free and control Hydra that were well-fed because the 
nutritional status of polyps can affect contraction rate95 and I reasoned that increased energy 
stocks might increase the differences in contraction rate between germ-free and control 
polyps. The hope was that an increase in effect size might allow for fewer animals to be used, 
speeding up the process of testing extracts or candidate molecules. 
 
Germ-free animals starved for three weeks contracted at 87 ± 4.5% (mean ± standard error) 
the relative contraction frequency of control animals (p = 0.11; n = 32 control, 58 GF; Figure 
12A). The decrease in contraction frequency was similar in the fed animals, with the average 
contraction frequency of germ-free polyps at 83.5 ± 5.6% relative to control animals (p = 0.02; 
n = 32 control, 31 GF; Figure 12B).  
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Figure 12. The contractions of germ-free animals are lower than the microbe-containing 
control animals. (A) Three week starved germ-free animals contracted at 87 ± 4.5% (mean ± 
standard error) the relative frequency of control animals (p = 0.11; n = 32 control, 58 GF). (B) 
Long-term, fed germ-free animals contracted at 83.5 ± 5.6% the relative frequency of the 
controls (p = 0.02; n = 32 control, 31 GF). 
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Effect of microbial extracts on contraction frequency 
To begin to assess the effects of microbial extracts on the contraction frequency of Hydra, I 
tested a negative control. This was important because the original report did not include a 
microbe-free extract41 and unpublished data from Dr. Murillo-Rincon indicated that the R2A 
medium used for microbial culturing has contraction-stimulating activity. If there was any R2A 
carried over into the microbe-free extract, it was not enough to elicit a measurable response 
of the germ-free polyps (p = 0.58; n = 41 GF, 35 vehicle control; Figure 13). 
 
 
 
Figure 13. There was no effect of the vehicle control extract on contraction frequency (p = 
0.58). 
 
 
Next, I tested the extract that was prepared the same way as previous extracts, using the 
native microflora of Hydra. Addition of this extract to germ-free polyps reduced the 
contraction frequency to 64.2 ± 5.2% relative to germ-free polyps with no extract added (p = 
1.10 x 10-5; n = 28 extract, 24 GF; Figure 14). 
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Figure 14. Addition of the extract containing the culturable microbial community of Hydra to 
germ-free polyps resulted in an unexpected decrease in contraction activity (p = 1.1 x 10-5; n 
= 28 extract, 24 GF polyps). 
 
 
Finally, I used only the five main colonizers to produce an extract. Recolonization of germ-free 
polyps with these five colonizers increased contraction frequency41, suggesting that a 
contraction-mediating molecule may be produced by co-culturing the five main colonizers. To 
test this, I created an extract using frozen glycerol stocks of these five strains and found that 
germ-free animals contracted 128 ± 7.3% more often when this extract was applied versus 
germ-free animals with no extract added (p = 0.25: n = 16 extract, 27 germ-free; Figure 15). 
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Figure 15. The new microbial extracts created with the five main colonizers increase 
contraction frequency by 28% relative to germ-free polyps (p = 0.035; n = 16 extract, 27 GF).  
 
16S analysis of native microbiota extract 
I was able to find four of the five main colonizing species of Hydra within the 16S sequences 
generated from the native microbiota extract. Duganella was not present, despite the fact 
that it is easily cultured on R2A agar96. Unfortunately, the 16S sequences of the original 
extracts was not tested41, so it is not possible to compare the 16S sequences of the new and 
old extracts. 
Metabolomic analysis of the five-microbe extract 
In the previously described mass spectrometry experiments, the scanning range was between 
m/z 147 – 1000. Glutamate and GABA are too small to have been detected using this method 
and it was important to look for these compounds because they are modulators of the 
feeding response duration and contraction frequency61, both of which are affected by 
microbes in Hydra41,42. Further, a new report found that the contraction frequency of Hydra is 
controlled by neurons that express acetylcholine receptors55, and again acetylcholine has too 
low a molecular weight to have been detected in my previous mass spectrometry experiment. 
Since bacteria are reported to produce a number of neurotransmitters97, I broadened my 
search criteria to include other neurotransmitters in my annotation results. Because the 
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scanning ranges of the two experiments overlapped, I was also able to look for the six mass 
traces common between the original extracts, in vitro-cultured microbes, and microbe-
containing Hydra.  
 
Of the 2740 compounds detected in the five-microbe extract, 197 were significantly different 
between the microbe-free and the five-microbe extracts. One or more of the 123 compounds 
higher in the microbe-containing extracts (Supplementary Table 5) could be responsible for 
the contraction-increasing behaviour attributed to these extracts, however, none of these 
mass traces matched with the six candidate molecules that overlapped between the three 
other mass spectrometry experiments. 
In vitro GABA production by the main colonizing species of Hydra 
Neither glutamate nor acetylcholine were increased in the microbe-containing extracts 
relative to the inactive microbe-free control. There was, however, an increase in GABA levels 
relative to the medium-only control (FC = 1.5, p = 0.018), suggesting that one or more of the 
main colonizing species of Hydra is able to produce GABA (Figure 16).  
 
 
 
Figure 16. The levels of GABA increased in microbe-containing compared to microbe-free 
culture media (FC = 1.5, p = 0.018). 
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The genomes of all five bacterial strains suggest GABA-metabolizing capabilities 
After obtaining the above results suggesting GABA production by Hydra microbiota, I set up a 
collaboration with Georgios Marinos (UKSH). Using his metabolic modelling approach, he 
found that the five main colonizing bacterial species of Hydra are able to produce GABA using 
putrescine as a precursor (Figure 17). However, only Duganella possess a GABA transporter, 
suggesting that the GABA present in mixed culture bacterial extracts may have originated 
from this strain (Supplementary File 6).   
 
 
 
 
Figure 17. All five of the main colonizing bacterial strains of Hydra are predicted to produce 
GABA based off of metabolic modelling results. Although the enzymes and pathways differ, 
e.g. Duganella is not predicted to use arginine as a precursor, all of the strains use 
putrescine as an intermediate in GABA production. Kyoto Encyclopedia of Genes and 
Genomes (KEGG)77 reaction identifiers are given in black. 
 
Putrescine, a GABA precursor, has varied effects on the growth of Hydra colonizers 
The modelling data predicts that all of the main colonizers of Hydra are able to metabolize 
putrescine to form GABA, which in turn can be used to produce the tricarboxylic acid (TCA) 
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cycle metabolite succinate98. Because of the link between putrescine, GABA and cellular 
respiration, I hypothesized that the bacteria may utilize putrescine as a growth substrate. 
 
The results for Curvibacter were striking: it grew better in 10 mM putrescine than in the 
standard culturing medium R2A (Figure 18). The strain grew so well in putrescine that the 
carrying capacity (the maximum population size for each medium type, given in absorbance at 
OD600; k) in 1 mM putrescine was indistinguishable from the carrying capacity of R2A (k1mM Put 
= 0.049 ± 0.002, kR2A = 0.045 ± 0.007, p = 0.64), and in 10 mM putrescine, the carrying 
capacity far exceeded that of R2A for this strain (k10mM Put = 0.40 ± 0.005, p = 7.2 x 10-11). As 
stated in the methods section, stationary phase was not reached in the cultures, so carrying 
capacity here is used as a proxy for biomass accumulation. 
 
Similarly, Duganella grew well in putrescine, but culture densities in R2A far exceeded those 
reached in either putrescine concentration (Figure 19). The carrying capacity of 1 mM 
putrescine (k1mM Put = 0.13 ± 0.002) was actually higher than that of 10 mM putrescine (k10mM 
Put = 0.056 ± 0.004; p = 0.00039), possibly owing to toxic effects at this concentration. 
 
Acidovorax, in contrast, began to grow well in 1 mM putrescine, but the culture crashed 
around 2.5 hours post-inoculation (Figure 20). This behaviour was not observed in 10 mM 
putrescine (Figure 20), where the culture declined with time. Pelomonas exhibited similar 
growth dynamics in 1 mM putrescine, crashing at around 7 hours post-inoculation and its 
culture density decreased with time in 10 mM putrescine (Figure 21). 
 
Perhaps the most surprising growth dynamics were exhibited by Undibacterium, where 
population densities began oscillating at about 10 hours post-inoculation (Figure 22). 
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Figure 18. The growth curve of Curvibacter using putrescine as the only carbon and nitrogen 
source. The standard growing medium R2A is included on this graph to demonstrate the 
superiority of 10 mM putrescine to elicit growth in this strain. Transparent area around the 
curve shows standard deviation from the mean. 
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Figure 19.Growth of Duganella in s-medium supplemented with 1 or 10 mM putrescine. 
Growth in R2A was higher than in putrescine and was therefore separated to better observe 
the growth dynamics in putrescine-containing media. Transparent area around the curve 
shows standard deviation from the mean. 
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Figure 20. The growth of Acidovorax in 1 and 10 mM putrescine. The standard growth 
medium used for culturing Acidovorax is R2A and included here as a positive control. 
Transparent area around the curve shows standard deviation from the mean. 
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Figure 21. The growth curve of Pelomonas with only putrescine as a carbon and nitrogen 
source. S-medium contains no energy sources and thus provides a baseline for growth from 
existing cellular resources. Transparent area around the curve shows standard deviation 
from the mean. 
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Figure 22. Growth of Undibacterium using only putrescine as a carbon and nitrogen source, 
with R2A and s-medium as positive and negative controls, respectively. Transparent area 
around the curve shows standard deviation from the mean. 
 
 
The chemoeffector prolyl-leucine is produced by Hydra and members of its 
microbiome 
One mass trace (m/z 227.1401), putatively annotated as prolyl-leucine, was chosen for follow 
up based on reports of the dipeptide acting as a chemoattractant in both eukaryotic and 
prokaryotic species99,100. This compound was 4-fold higher in germ-free polyps compared to 
control polyps (p = 9.7 x 10-8; Figure 23) and produced by Undibacterium and in co-culture 
(ANOVA p > 0.0001; Figure 24).  
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Figure 23. A mass trace matching the expected mass of the dipeptide prolyl-leucine is 4-fold 
higher in germ-free polyps relative to control polyps (p = 9.7 x 10-8).  
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Figure 24. The putative dipeptide was also produced by Undibacterium and detected in co-
culture, but not by the other main colonizers (ANOVA p < 0.0001).  
 
MS/MS fragmentation is consistent with dipeptide annotation but unable to 
differentiate between the isomers 
Fragmentation of the m/z 227.1401 mass trace was successful, but there were fragments 
matching all of the isomers present. This indicates that the mass trace may represent several 
chemical species, i.e. prolyl-leucine, leucyl-proline, isoleucyl-proline and prolyl-isoleucine may 
all be present in the sample. 
Non-ribosomal peptide synthetases are predicted to be present in four of five main 
colonizers 
I used antiSMASH to search the bacterial genomes for the metabolic potential to produce 
various secondary metabolites because having additional information about the metabolic 
potential of the bacterial strains could help with compound annotation. Putative non-
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ribosomal peptide synthetases were identified in all of the genomes of the main colonizers 
except Acidovorax (Table 1), suggesting the bacteria may produce bioactive cyclic peptides or 
short peptide fragments.  
 
 
Table 1. Secondary metabolite classes predicted to be produced by the main colonizers of 
Hydra based off of putative annotation from antiSMASH. 
 Secondary metabolite class Pelo Undi Acido Dug Curvi 
Acyl amino acids 4 0 1 2 0 
Lanthipeptide 1 0 0 0 0 
NRPS 1 1 0 2 1 
Terpene 1 1 1 1 1 
Bacteriocin 3 2 3 0 1 
NRPS-like Homoserine lactone 1 0 0 0 1 
NRPS, T1PKS 1 0 0 0 0 
Homoserine lactone 0 1 0 0 1 
Siderophore 0 1 0 0 0 
Betalactone 0 0 1 0 2 
NRPS-like 0 0 0 0 1 
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Discussion 
Adult neurogenesis is not influenced by the microbiota of Hydra 
There was no detectable influence of Hydra microbiota on neurogenesis or the nerve cell 
density of adult polyps (Figure 4Figure 5). Notably, we cannot rule out the possibility that the 
microbiota in Hydra play a role in early-life neurogenesis, as this study was performed on 
adult animals.  
 
The influence of Hydra microbiota on feeding and contraction responses was observed in 
polyps that were allowed to develop to adults in the presence of their microbiota41,42. Clearly 
the microbes are interacting with the nervous system in some way, as contraction frequency 
and feeding duration are both nervous system-dependent behaviours55. As I mentioned in the 
introduction, microbiota can influence both nervous system anatomy and function. There is 
still the possibility that resident microbiota affect the anatomy of the Hydra nervous system 
at the cellular level, as I did not assess changes to neuron morphology. Alteration of dendritic 
branching has been observed in mouse and rat studies101,102, and this could play a role in 
microbiota-nervous system interactions in Hydra as well. 
 
For example, neuron morphology in rats is permanently altered through prenatal inhibition of 
the production of the kynurenine pathway, involved in tryptophan catabolism102. Microbial 
metabolism is hypothesized to alter the flux of metabolites through the kynurenine pathway, 
with these alterations playing a role in some microbiome-related pathologies103. In germ-free 
mice, hippocampal pyramidal neurons are shorter and less branched than those of 
conventionally-raised mice, effectively reducing the overall number of synaptic connections in 
that brain region101. Diaz et al. (2011) demonstrated altered behavioural activity of germ-free 
mice and found concurrent changes to the expression of synaptogenesis-related proteins, 
providing further evidence that changes to nerve cell structure can be mediated by the 
microbiota. It would be interesting to observe the finer structure of neurons in germ-free 
polyps to see if similar changes occur in Hydra. 
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A metabolomics pipeline for the identification of bacterially-derived compounds 
influencing host metabolite profiles 
Another possibility is that contraction frequency and feeding duration are altered through 
modulation of nervous system function, be it direct or indirect. At least in the case of 
contraction modulation, we can assume alteration of the nervous system function rather/also 
plays a role because the addition of microbial extracts to germ-free polyps increased 
contraction frequency after an incubation period of only about 16 hours41,42, and it seems 
unlikely that much rewiring can take place so quickly in 4-week starved polyps. One of the 
aims of this study was to identify which of the bacterially-derived molecules in the extracts 
were responsible for the observed increase in contraction frequency. By analysing these very 
extracts on a high-resolution mass spectrometer, I was able to find 1188 unique mass traces. 
To reduce the chemical complexity, I designed an approach based on where the contraction-
mediating compound could be assumed to be present. I made the following assumptions: (1) 
microbe-containing animals should have higher concentrations of the active compound than 
germ-free animals and (2) the molecule can be produced in vitro based on the biological 
activity of the in vitro-produced extracts.  
 
First, I subjected germ-free and control polyps to mass spectrometry analysis. The difference 
between the metabolomic profiles of germ-free and control is nicely reflected in both the PCA 
plots and heatmaps (Figure 7 Figure 8). To find the contraction-mediating compound, only 
mass traces high in control animals are important, so I used a volcano analysis (Figure 9) to 
find compounds high in control animals relative to germ-free animals (FC > 1.5, p < 0.05). I 
compared these 127 mass traces to the clearly unique (based off of PCA and heatmap results, 
(Figure 10Figure 11) metabolomic profiles of the individual colonizers and the metabolomic 
profiles of the two original extracts. It is important to note that I did not restrict the 
comparison of the bacterial dataset to compounds high in the co-cultured sample, as the 
activity of the in vitro monocultures was unknown. This comparison yielded 6 unique mass 
traces (Supplementary Table 3). Regrettably, none of the 31 annotations (Supplementary 
Table 4) for these mass traces had links to contraction activity of Hydra. I searched the 
literature for contraction-mediating effects of the compounds in any organism, evidence of 
interaction with acetylcholine receptors, and gap junction proteins (gap junction signalling is 
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an important influencer of contractions in Hydra104). I also used KEGG and HMDB to look for 
links to known metabolic pathways. 
 
Many of the hits seemed potentially spurious. The 17 potential identities were often plant-
associated metabolites for the mass trace measured at m/z 365.1373 (Supplementary Table 
4). Picrocrocin, is a metabolite of saffron that inhibits the growth of cancer cells105. 8-
epiiridodial glucoside is an intermediate in the production of plant iridoid glucosides106. 
Similarly, iridodial glucoside is a precursor for other iridoid glucosides found in plants107. The 
various glucoside derivatives were also mainly associated with plant production108. 
Portuloside A is likewise a monoterpene glucoside isolated from purslane (Portulaca 
oleracea)109. Epijasminoside A contains a glycoside bonded to a sugar compound (compound 
class: o-glycosyl compounds) and was isolated from jasmine (Gardenia jasminoides)110. The 
various isomers of schizonepetoside are monoterpene glucosides derived from Japanese 
catnip (Schizonepeta tenuifolia)111–113. Importantly, all of the main colonizers contain 
biosynthetic gene clusters for terpene production (Table 1). There is a huge variety of 
terpenes and glucosides in nature, and some of them do interact with the nervous system in 
various ways114,115. 
 
Tetranor-PGFM, on the other hand, is structurally quite different than the other isomers. It is 
a prostaglandin that has been found in urine and faeces of mammals and is an apparent 
marker for pregnancy in cats and pandas116,117. Unlike the other metabolites matching m/z 
365.1373, prostaglandins as a metabolite class have been reported in cnidarians, where they 
seem to be important for defense118. 
 
The compounds matching the expected mass of m/z 349.1423 were, again, plant-associated. 
(-)-trans-carveol glucoside, (+)-trans-carveol glucoside, and perilloside A are monoterpene 
glycosides108,119,120.  
 
Moving on to hits matching m/z 363.1216, again there are glucosides and prostaglandins. 
Finally, m/z 363.158 has only one hit: (10S)-juvenile hormone III diol phosphate, an insect 
hormone77. The final two mass traces measured at 347.1267 and 361.1423 did not match any 
metabolites in the databases searched. 
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In the end, there was not a strong enough case to test any of the 31 compounds that could 
represent the six candidate mass traces – essentially, they all seem to have similar 
probabilities of being a bacterially-produced, contraction-regulating molecule. Applying each 
of the compounds here to germ-free Hydra is theoretically possible, of course, but it does not 
fit within the timeframe of a PhD project. It is possible that the answer lies within these six 
mass traces: bacteria do indeed produce compounds often recognized as plant metabolites, 
for example, and the molecules listed do generally belong to bioactive compound classes. The 
fact that these six compounds were not measured in the five-microbe extract does not 
necessarily mean they were not there since they were measured on a different mass 
spectrometer. It’s possible that the true identity of the compounds was not found because it 
simply was never input into the databases searched, or even more intriguingly, has never 
been identified before.  
 
Another possibility that would explain the lack of a suitable candidate using this approach is 
that the contraction-regulating compound(s) lie outside of the scanning range of the mass 
spectrometer or were not ionized and therefore were not detected. For example, 
neuropeptides are important relayers of information in the Hydra nervous system, and some 
even interact directly with the microbiome121–123.These compounds are too large to have 
been detected with the mass spectrometer settings used. Smaller compounds, for example 
the amino acid neurotransmitters GABA, glycine and glutamate are too small for detection. 
 
We must also consider the possibility that the assumptions made to make these comparisons 
were faulty. Perhaps the compound(s) were not produced at all in the in vitro assays, which 
were cultured in liquid R2A instead of R2A-agar. To get high enough levels of the 
compound(s), perhaps less abundant members of Hydra microbiota needed to be present. 
For these reasons, I also investigated the mass traces present in the extract and in Hydra, 
which adds a further 13 annotations, but as before, none of the compounds stood out as 
plausible contraction-mediating compounds. Lastly, I looked at the compounds present in the 
in vitro cultured microbes and the extracts, because if the compound(s) were not present in 
high enough levels in whole polyps, they would not have made it through the pipeline. There 
were 144 mass traces common between the two mass spectrometry experiments, with 1818 
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annotations. Obviously, the data need to be reduced significantly for a thorough investigation 
of these compounds.  
Advances towards a fractionation-based approach for contraction-mediating molecule 
identification 
Without a strong candidate for a contraction-mediating molecule, I adjusted my approach. A 
standard approach for bioactive molecule identification is to chemically fractionate bioactive 
extracts and test the fractions for biological activity. For example, one could use C18 solid-
phase extraction with increasing concentrations of methanol. Some molecules will elute at 
low methanol concentrations and others at higher concentrations, and the fractions with 
elevated levels of a bioactive compound will have the most biological activity (assuming a 
dose-dependent effect). Importantly, this approach can help in the identification of so-called 
“unknown unknowns”, which are metabolites that have never before been described124. 
 
To work towards this approach, I began by replicating the methods of the original study41,42. 
My results are congruent with that study; however, the magnitude of the effect was smaller 
(Figure 12A). Germ-free animals contracted at 87 ± 4.5% the relative frequency of control 
animals (p = 0.11), while in the previous study the germ-free animals contracted at roughly 
60% the frequency of control animals41. The difference in the effect size could have arisen 
due to differences in our handling of the polyps, which become quite small and fragile in the 
absence of food. Another possibility is that the microbiota changed over time and that the 
microbiota of the polyps I worked with was less effective at increasing the contraction rate. 
When I extracted the metabolites of the resident microbiota using Dr. Murillo-Rincon’s 
technique, the extract unexpectedly decreased contraction frequency (Figure 14), lending 
credence to the latter hypothesis. Further, the 16S sequences of the negative-acting extract 
did not contain Duganella, a strain easily cultured on R2A agar. Although it could have been 
outcompeted on the plate, when taken together, the evidence suggests a change to the 
microbiota that influenced the contraction rate. 
 
The nutritional status of Hydra polyps influences its contraction frequency – contractions 
increase with increasing feeding frequency95. Hoping to see a greater effect size or less 
variability within treatments in well-fed animals, I also assessed the contraction frequency in 
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our long-term germ-free culture. This could have reduced the number of replicates required 
to see an effect, increasing my capacity to perform the assay. Unfortunately, the effects were 
quite similar to those of the starved polyps, with the contractions of germ-free animals 
occurring at 83.5 ± 5.6% the relative frequency of the controls (p = 0.02; Figure 12B).   
 
I performed the rest of the behavioural assays on starved polyps, first addressing the issue of 
a missing negative control on contraction frequency. This extract had no effect on contraction 
of germ-free polyps (Figure 13). I concluded from this that the vehicle control does not have 
appreciable levels of contraction-mediating compounds. Next, I created an extract using only 
the main colonizers of Hydra, which were able to increase contraction frequency when they 
were used to recolonize germ-free Hydra41 (Figure 2B). This extract increased contraction 
frequency of germ-free polyps to 128 ± 7.3% (p = 0.035; Figure 15). In Dr. Andrea Murillo-
Rincon’s experiments, her microbial extracts were created by homogenizing Hydra polyps and 
culturing the microbes in the homogenates. These extracts increased contractions to 148% 
relative to the germ-free polyps (averaged between the two extracts tested). The difference 
in the activities in the extracts could very well have arisen due to the presence of less 
abundant, but biologically important, members of the Hydra microbiota. Interindividual 
variation in contraction frequency is also quite high61, and the assay does have some 
subjective aspects (it is not always clear whether or not a potential contraction should be 
counted). These may have played some role in the observed differences in effect size. In any 
event, the result was a bioactive extract whose microbial composition was known and easily 
reproduced. 
 
This extraction method could be employed in future studies in a fractionation-based 
approach. However, I would recommend taking advantage of recent advances in the field to 
move towards a higher throughput bioassay. Researchers have developed a whole-body 
calcium imaging system that allows for simultaneous investigation of several polyps and it was 
successfully employed to measure contraction frequency under different biotic and abiotic 
conditions (osmolarity, temperature, nutrition, and body size)125. In this experiment, five 
animals were place together in a single well. It may be possible to do the same without 
resorting to changing the setup used in the present work (in this work, each well contained a 
single polyp). In another study, a machine learning algorithm was used to characterize and 
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quantify Hydra behaviour126. Automating behavioural quantification could improve 
throughput and allow for simultaneous investigation of the other five behaviours this 
algorithm recognizes (elongation, tentacle swaying, body swaying, elongation and silent). 
Applying the metabolomics pipeline for identification of other bioactive molecules 
influencing host-microbe dynamics 
As mentioned in the introduction, microbes do not only influence host behaviour, but many 
aspects of host physiology. From the perspective of the host then, it seems prudent to have 
some control over its microbial colonizers. Indeed, there is evidence that hosts can influence 
their microbial community’s composition. The host immune system can manipulate the 
community composition of its microbiota through, for example, the production of 
antimicrobial peptides127. In Hydra, the nervous system can play a direct role in host-led 
microbial community composition alteration through secretion of neuropeptides that have 
antimicrobial effects122.  
 
Host-derived compounds that increase the abundance of particular bacterial strains, rather 
than acting through antimicrobial mechanisms, seem to be less reported in the literature. 
However, evidence suggests that these types of host-led microbial community changes occur 
as well. For instance, human breast milk contains oligosaccharides that may influence the 
microbial community composition of breast-fed infants128. Furthermore, recent, as yet 
unpublished work from Dr. Peter Deines revealed that germ-free Hydra polyps elicit microbial 
chemotaxis to a greater degree than microbe-containing polyps92. This could suggest that 
germ-free Hydra produce a chemotaxis-eliciting molecule that may even shape microbial 
community composition.  
 
I searched the metabolome of germ-free Hydra for compounds that may be responsible and 
found that germ-free Hydra produce a dipeptide with known chemotaxis-eliciting activity 
(Figure 23). This dipeptide, tentatively labelled prolyl-leucine, elicits chemotaxis in Escherichia 
coli through the action of the Tap signal transducer and a dipeptide permease99. This 
annotation is considered tentative because of the possibility that proline is on the C- rather 
than the N- terminus (i.e. the mass trace could represent leucyl-proline). These compounds 
have the same molecular weight and therefore cannot be distinguished by m/z alone, but 
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both of them elicit chemotaxis in bacteria99. Similarly, leucine has a structural isomer, 
isoleucine, further complicating the analysis.  
 
To confirm the identity of the dipeptide, we used MS/MS to obtain its fragmentation pattern. 
This was performed on a sample from Undibacterium, which also produces a compound 
measured at m/z 227.1401 (Figure 24). Undibacterium was used because MS/MS is less 
sensitive than mass spectrometry alone and it is possible to grow significant quantities of 
bacterial culture. The fragmentation pattern contained fragments associated with all four 
potential dipeptide identities, and this could indicate that multiple isomers are present in the 
sample. Further, I cannot rule out the possibility that a D-enantiomer is present. It may be 
possible to use a fractionation-based approach to further isolate the compound(s) and 
perhaps identify the mass trace with higher confidence.  
 
Dipeptides can be formed through a few mechanisms, including nonribosomal peptide 
synthetases (NRPS)129. These enzymes can also accept D-amino acids130 and could be 
responsible for the formation of the dipeptide measured at m/z 227.1401. Using the bacterial 
genomes of Curvibacter, Acidovorax, Duganella, Undibacterium and Pelomonas, I searched for 
evidence of secondary metabolite biosynthesis gene clusters. Undibacterium contained one 
NRPS cluster, which could potentially be involved in dipeptide production (Table 1). 
Moreover, the analysis predicted the presence of NRPS gene clusters in Curvibacter, 
Duganella and Pelomonas. Considering the importance of peptide signalling in the nervous 
system of Hydra, these gene clusters deserve more attention. Further, the Pelomonas 
genome encodes 12 distinct secondary metabolite synthesis gene clusters. Bearing in mind 
the capabilities of this strain to increase contraction frequency of Hydra, one might examine 
these results in further detail. 
Mass spectrometry analysis of in vitro cultured Hydra microbiota and metabolic 
modelling reveals in vitro production of the neurotransmitter GABA 
With the influence of Hydra microbiota on two nervous system dependent behaviours41,42, 
and in the absence of obvious changes to nervous system anatomy, I turned to the microbial 
extracts to look for bacterially-derived molecules that influence nervous system function. 
Neural excitability can be influenced directly through the action of bacterial metabolites, for 
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example, the short chain fatty acid butyrate increases excitability of enteric neurons in a 
dose-dependent manner131. Bacterial production of neuroactive compounds, including GABA, 
dopamine, acetylcholine, and 5-hydroxytrytamine, may also impact nervous system 
function132.  
 
In the five-microbe extract, the neurotransmitter GABA was present in higher amounts than 
in the medium-only control (Supplementary Table 5, Figure 16). A second line of evidence 
that Hydra colonizers produce GABA comes from the modelling work of Georgios Marinos 
(Figure 17). These results suggested the presence of putrescine-dependent GABA production 
in all five main colonizers, though a transporter for secretion of GABA was only present in 
Duganella. Much of the GABA in the five-microbe extract therefore likely arose from this 
strain.  
 
As mentioned in the introduction, GABA increases the duration of the feeding response in 
Hydra61, and an unknown interaction between Hydra and its microbiota also increases the 
feeding response. Could GABA be one of the microbially-derived compounds influencing 
feeding duration in Hydra? This is possible, but more evidence is needed. Examining the levels 
of GABA in germ-free, control and recolonized polyps would be a good first step at 
understanding the role of microbially-produced GABA on Hydra. Bearing in mind that of the 
five main colonizing bacterial species, only Duganella has a high likelihood of influencing host 
levels through GABA secretion, it would be wise to confirm the modelling results by looking 
for GABA production by Duganella in vitro. This would link nicely to a series of 
monocolonization experiments with the five colonizers. The expectation would be that 
Duganella would be the most effective at prolonging feeding duration. The in vivo assay is 
important here because Duganella may reduce host levels of GABA by using the antiporter to 
uptake GABA for use in the TCA cycle, rather than producing GABA. 
 
Importantly, microbiota often affect behaviours through several mechanisms, and other 
mechanisms may play a role when it comes to microbial effects on the feeding response of 
Hydra. Reduced glutathione is used to elicit the feeding response in Hydra. This compound 
was initially isolated from food extracts and is sensitive to oxidation by hydrogen peroxide133. 
It is noteworthy that recent work from our lab uncovered aberrant peroxidase activity in 
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germ-free polyps134. This hydrogen peroxide-reducing enzyme, usually restricted in its 
expression to the foot region, was expressed in seemingly random hot spots along the body 
of germ-free polyps. We might expect an increase in peroxidase expression in the presence of 
increased hydrogen peroxide, as this has been demonstrated for other peroxidase 
enzymes135. Could this imply an increase in hydrogen peroxide concentrations in germ-free 
polyps? If increased levels of hydrogen peroxide are also present externally, we might expect 
a faster rate of glutathione oxidation in germ-free polyps, terminating the feeding response 
earlier than in control polyps. Additionally, other recent work from the Bosch lab revealed 
that germ-free Hydra have higher concentrations of reactive oxygen species (ROS) than 
control animals (the assay measured the ROS in the surrounding medium) which further 
supports the hypothesis that oxidation of reduced glutathione may contribute to the 
shortened feeding response duration in germ-free polyps136. This hypothesis could be tested 
by assessing the levels of oxidized, reduced and total glutathione after incubation with germ-
free, conventionalized and control polyps; a colorimetric assay for this is readily available.  
GABA links to core metabolic pathways in Hydra colonizers 
The microbial production of GABA may influence Hydra, but why is it that the bacteria 
produce the compound at all? The lack of a secretory mechanism for GABA in four of the five 
bacterial strains searched (Figure 17) suggests that GABA is used for some intracellular 
processes. Indeed, GABA can be degraded to succinate, which feeds directly into the TCA 
cycle. Of course, the TCA cycle is a central metabolic pathway that provides energy to cells. 
This implies that GABA production could be an intermediate in a core metabolic pathway 
where putrescine supplies energy to resident microbiota. Putrescine has been detected in 
Hydra via high-performance liquid chromatography (HPLC)137, so putrescine could 
theoretically be host-supplied. Any GABA release may simply be a by-product of the use of 
putrescine in central bacterial metabolism. In fact, it has been hypothesized that bacteria 
elicit behavioural changes in their hosts as a result of their core metabolic processes, rather 
than production for outright host behaviour manipulation138.  
 
To investigate the role of putrescine in core bacterial metabolism, I cultured Cuvibacter, 
Undibacterium, Duganella, Pelomonas and Acidovorax in a medium containing only 
putrescine as a carbon, nitrogen, and energy source. All the strains achieved higher densities 
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in s-medium (Hydra growth medium containing only salts) supplemented with putrescine 
than they did in s-medium alone, suggesting that all strains were able to uptake and utilize 
putrescine to some degree (Figure 18-22). This preliminary experiment needs to be repeated 
with a higher initial inoculum density because the cultures did not reach stationary phase, but 
the data nevertheless look promising. Additionally, the results are corroborated by a 
substrate utilization assay which demonstrated that all five strains are able to use putrescine 
as a carbon source139. 
 
Perhaps most strikingly, Curvibacter grew to higher densities in 10 mM putrescine than it did 
in the standard growth medium, R2A (Figure 18). In the other strains, 10 mM putrescine 
seemed somewhat inhibitory relative to 1 mM putrescine, likely owing to putrescine’s toxic 
effects140. Undibacterium also had curious growth dynamics, with an oscillating pattern in the 
presence of putrescine that was not observed in R2A or s-medium (Figure 22). These kind of 
growth dynamics have been reported before for bacteria grown in the presence of 
bacteriophages141. Indeed, Undibacterium does harbour a temperate phage142 so this is a 
plausible hypothesis, and could be confirmed by examining putrescine-supplemented 
Undibacterium cultures for phages. 
 
Thus, it appears that GABA production via putrescine is part of core bacterial metabolism, and 
is not produced to manipulate host behaviour, just as Johnson and Foster predicted138. Why 
Duganella secretes GABA is still an open question. In Pseudomonas fluorescens, exposure to 
GABA reduces biofilm formation and alters cell envelope structure (specifically 
the lipopolysaccharide component lipid A)143. In Agrobacterium tumefaciens, exposure to 
GABA reduced the levels of the quorum sensing molecule N-(3-oxooctanoyl)homoserine 
lactone (OC8-HSL)144. Duganella appears to produce OC8-HSL as well145, but it is unclear what 
effect the quorum sensing molecule has on Duganella. Considering that GABA can apparently 
be used for growth in Duganella, I would predict GABA secretion primarily in high nutrient 
environments. This could mean that the OC8-HSL is produced preferentially in low nutrient 
environments. If GABA and OC8-HSL are negatively correlated as they are in A. tumefaciens, I 
would predict that OC8-HSL may elicit changes in Duganella that are important for survival 
under nutrient-limited conditions (e.g. reduction of biofilm formation146). 
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Challenges and future directions 
This is the first untargeted study of the Hydra metabolome, and the first to find that there is a 
demonstratable effect of microbes on the metabolism of Hydra. Similarly, studies in mammals 
have demonstrated the strong effect microbes have on host metabolomes by comparing the 
metabolomes of blood and tissue samples from germ-free and microbiota-containing 
hosts147,148. Understanding what metabolites in these perturbed profiles are microbially-
derived and what microbiota members are capable of producing the compounds continues to 
be an area of difficulty in metaorganism metabolomics studies63. One strategy is to compare 
the metabolomic profiles of germ-free and microbe-containing hosts with the metabolomic 
profiles of the bacterial colonizers. 
 
The data generated in the current study provide the means to do just that: 30 mass traces are 
common between the microbial dataset and high in control polyps. Although outside of the 
scope of the current study, some of these mass traces could represent important compounds 
in host-microbe co-metabolism or dynamics. This could represent a novel way to identify 
bacterially-derived metabolites in vivo. A similar approach has been employed using the 
HuMiX system (human-microbial cross-talk), where human cell lines are grown in co-culture 
with bacteria found in the human gut microbiome and the metabolomics profiles can be 
compared to those of monocultured cells149. Using only a cell line is unlikely to recapitulate 
the complexities of the whole system, however. In another study, researchers were able to 
identify compounds produced by Clostridium sporogenes in monocolonized mice after 
screening in vitro cultures for bioactive compounds63. 
 
In contrast, here I suggest a way to probe the entire metabolome of a metaorganism with 
concurrent investigation of the metabolomes of the majority of its bacterial colonizers, 
allowing for tracing of microbially-derived metabolites.  This unique situation arises as a result 
of the utility of the model Hydra in metaorganism research: specifically, Hydra’s clonal nature, 
soft body and small, species-specific microbiome.  
 
One of the major challenges in this study was compound annotation: identifying the 
compound that is represented by a particular mass trace. This is a major bottleneck in any 
metabolomics study150. In the current work, I use databases to search for putative mass trace 
 72 
identities and often found a single mass trace could represent one of any number of 
compounds. Options for annotation based off of metabolic models is possible (e.g. using 
Mummichog151) but mostly restricted to humans or well-established model systems. This 
approach naturally restricts the compound annotations to compounds predicted to be 
present based on genomic information. This means that some of the mass traces will remain 
unannotated, and the compounds representing these mass traces may play an important role 
in the system. For example, enzymes often catalyze reactions with multiple substrates: some 
of the reactions may not be identified. There is also the problem of genes of unknown 
function (from both host and microbiota) which contribute to metabolism in unaccounted for 
ways. Specific to metaorganism metabolomics, the hologenome is not considered in the 
creation of the models and therefore microbially-derived metabolites could easily remain 
unannotated.  
 
One option for improved compound annotation is to use gas chromatography-mass 
spectrometry (GC-MS). The retention time of metabolites in the column is highly reproducible 
and by combining the retention time with an accurate mass, more reliable compound 
annotation can be accomplished. Tandem mass spectrometry (e.g. MS/MS) can also be used 
for compound identification thanks to the reproducible nature of the chemical 
fragmentations induced by MS/MS. In any event, an annotated compound list can be used for 
chemical similarity enrichment analysis (ChemRICH)152. This tool uses chemical similarities 
rather than metabolic models to understand the data structure in a way that is genome-
independent, which is an important consideration in metaorganism metabolomics. 
 
By comparing the metabolomes of microbe-containing Hydra, its microbial colonizers and 
contraction frequency-increasing extracts, I was able to identify six candidate masses that 
may influence contraction frequency. Here the problem with mass spectrometry annotation 
was obvious: none of the annotations for the six mass traces seemed likely to be of microbial 
origin, with most of the annotations being specific to plants. Had the six traces corresponded 
to six compounds, the molecules could have been tested directly for contraction-regulating 
activity. To get a high-confidence identity on these mass traces, MS/MS could be performed, 
but more samples would be needed. To move forward with the identification of bacterially-
derived, contraction-mediating molecules, I would recommend focusing on using the five-
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microbe extraction method to fractionate the extracts and test each fraction for bioactivity. 
Using this approach, one should be able to scale up the production of the samples which 
could allow for compound identification using, for example, GC-MS or MS/MS. To accomplish 
this, an increase in the throughput of the behavioural assay is recommended. 
 
Another challenge of the present study was the apparent changes to the resident microbiota 
of Hydra between this study and the previous study that demonstrated the effect of 
microbiota on the contraction frequency of Hydra. There seems to have been a reduction in 
the size of the contraction-mediating effects of microbiota between the two studies. In 
addition, the microbial extract I created using the established method had unexpected 
contraction-reducing activity (Figure 14). By using only the main colonizers, which had already 
been demonstrated to partially restore contraction frequency122, I was able to create an 
extract that increased contraction frequency. Synthetic microbial communities are an 
important tool for metaorganism research because it allows reproduction of results over time 
or between labs. This is demonstrated nicely here, as I relied on the results of the contraction 
assay using animals colonized with the five-member minimal consortia to inform my own 
experimental design. As more labs catch on to the utility of Hydra as a model metaorganism, 
synthetic communities like the five-member minimal consortia will become very useful, 
allowing easy discourse between labs. 
 
Hydra biology has been studied for over a hundred years52 and our knowledge of the biology 
of the individual colonizing strains is nowhere near as advanced. Here, this was demonstrated 
most clearly in the growth curves for Curvibacter and Undibacterium in putrescine-containing 
media. Curvibacter is the most abundant colonizer of Hydra, yet performs the worst of the 
main colonizers when grown on the standard medium (R2A)153. Could putrescine uptake and 
utilization give Curvibacter a competitive edge in vivo? One could approach this question by 
setting up a series of competition experiments between Curvibacter and the other colonizers. 
The growth curve of Undibacterium hints at the intriguing possibility that a host metabolite 
can cause prophage induction. This possibility should be examined further as bacteriophages 
can be an important regulator of microbiome composition154. 
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Just how important is putrescine for host-bacteria interactions? Putrescine and other 
polyamines have a wide variety of effects on micro- and macro-organisms. They are called 
polyamines because they contain multiple positively charged amino groups (-NH3+) and these 
positively charged groups allow them to interact with negatively-charged molecules like DNA, 
RNA and proteins155. Polyamines can act as antioxidants, increase cell proliferation, influence 
bacterial swarming behaviours, affect DNA and protein synthesis, and influence 
apoptosis156,157. The concentration of polyamines decreases with age, and supplementation 
can improve lifespan, but too much of a good thing may be detrimental: polyamine 
concentrations also increase in tumors155. Hydra polyps contain putrescine137, but its 
physiological effects are unclear. The existence of putrescine-degradation pathways in all five 
main colonizers of Hydra suggests that these bacterial strains may impact putrescine levels in 
vitro. Understanding the impact of putrescine on Hydra physiology and the effects that its 
microbiota have on putrescine levels could prove an interesting avenue for future studies. 
Summary 
Hydra’s resident microbiota are able to interact with its nervous system, manipulating its 
contraction frequency and feeding response41,42. In this report, I investigate the possible role 
of microbially-dependent alterations to nervous system structure and function. Nervous 
system structure in adult polyps, in terms of neurogenesis and nerve-cell density was not 
impacted by microbes in Hydra, suggesting the alteration of nervous system function is the 
more likely mechanism through which this occurs. To understand what bacterial metabolites 
might play a role in altering nervous system function, I developed a metabolomics pipeline to 
identify metabolites of bacterial origin in vivo. This pipeline can be used to determine what 
colonizers produce a particular compound, provided that compound is produced in vitro. 
Although I was not able to identify the molecule responsible for bacterially-dependent 
contraction modulation in Hydra, this pipeline has utility beyond the function it was initially 
developed for. For example, as recent results from the lab suggested the production of a 
chemotaxis-eliciting compound in germ-free Hydra92, I used the pipeline to search the 
metabolome of germ-free Hydra, and identified a candidate chemotaxis-eliciting dipeptide.  
 
Finally, to look for evidence of functional manipulation of the Hydra nervous system by its 
bacterial colonizers, I checked for the in vitro production of neurotransmitters by Hydra 
 75 
microbiota and found that the colonizing bacteria produced GABA in co-culture. Metabolic 
modelling results suggest that all five main colonizers can metabolize GABA, but only 
Duganella possessed the transporter required for GABA secretion. As the feeding response 
can be prolonged through exogenous application of GABA61, bacterial production of GABA 
may be one way that bacteria increase feeding response duration. 
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Supplementary Information 
Supplementary Table 1. The internal calibration list used to calibrate the raw mass 
spectrometry data. 
Formulae m/z z 
C11H20O4 215.128884 1- 
C12H21NO4 242.139783 1- 
C13H20O5 255.123799 1- 
C11H20N2O7 291.119777 1- 
C17H28O3S 311.168641 1- 
C19H32O3S 339.199941 1- 
C18H32N2O5 355.223847 1- 
C19H36N2O5 371.255147 1- 
C20H36N2O6 399.250062 1- 
C23H36O8 439.233744 1- 
C21H37N3O7 442.255876 1- 
C18H30O12S 469.138526 1- 
C25H45N3O7 498.318476 1- 
C27H49N3O7 526.349776 1- 
C29H53N3O7 554.381076 1- 
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Supplementary Table 2. Relative abundances of the OTUs detected in the control Hydra used for metabolomics analysis. 
OTU ID % Abdundance Taxa 
 C1 C2 C3 C4 C5 Phylum Class Order Family Genus 
545507 
(Acidovorax) 8.52 22.37 6.85 24.76 6.11 Proteobact. β-proteobact. Burkholderiales Comamonad. Acidovorax 
750018 1.46 18.59 0.11 14.37 2.11 Proteobact. !-proteobact. Pseudomonadales Pseudomonad. Pseudomonas 
586766 2.03 14.18 11.12 10.87 2.45 Proteobact. !-proteobact. Alteromonadales Chromatiaceae Rheinheimera 
OTU1073 
19.2
3 7.69 26.84 2.31 0.05 Proteobact. β-proteobact. Burkholderiales Comamonad.  
4391034 
(Pelomonas) 0.31 7.52 0.64 1.53 0.44 Proteobact. β-proteobact. Burkholderiales Comamonad.   
OTU914 0.09 5.10 11.39 5.51 0.70 Bacteroidetes Flavobacteria Flavobacteriales Flavobacteriaceae Flavobacterium 
OTU1107 
13.8
1 3.57 5.75 2.86 0.25 Unassigned     
OTU657 2.27 2.80 3.94 2.96 2.18 Unassigned     
538007 7.05 2.38 7.04 4.10 0.06 Proteobact. !-proteobact. Legionellales Legionellaceae   
750411 
(Cuvibacter) 0.82 2.23 0.14 0.05 0.01 Proteobact. β-proteobact. Burkholderiales Comamonad.   
OTU718 1.18 1.92 2.23 1.86 1.07 Unassigned     
564678 0.43 1.78 0.63 3.31 0.01 Proteobact. !-proteobact. Pseudomonadales Pseudomonad. Pseudomonas 
141316 0.13 0.66 0.27 0.64 0.30 Proteobact. β-proteobact. Burkholderiales   
578551 0.59 0.65 0.25 3.28 5.29 Proteobact. α-proteobact. Sphingomonadales    
OTU706 0.08 0.57 0.24 0.00 0.03 Proteobact. α-proteobact. Rickettsiales    
336824 0.01 0.44 0.04 0.10 0.07 Proteobact. β-proteobact. Burkholderiales Comamonad.   
4426763 1.60 0.42 0.36 11.24 
19.0
3 Proteobact. β-proteobact. Burkholderiales Comamonad.   
4316205 0.02 0.37 0.17 0.33 0.15 Proteobact. !-proteobact. Alteromonadales Chromatiaceae Rheinheimera 
OTU1176 0.03 0.35 0.31 0.32 0.29 Proteobact. β-proteobact. Burkholderiales Comamonad. Acidovorax 
1136511 0.11 0.34 0.44 0.14 0.01 Proteobact. β-proteobact. Burkholderiales Comamonad.   
OTU1229 0.00 0.33 0.12 0.18 0.02 Proteobact. !-proteobact. Pseudomonadales Pseudomonad. Pseudomonas 
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256215 2.32 0.33 0.00 2.44 0.43 Proteobact. !-proteobact. Pseudomonadales Pseudomonad. Pseudomonas 
1787644 0.00 0.31 0.00 0.01 0.14 
Cyanobacteri
a Chloroplast Streptophyta    
OTU471 0.01 0.29 0.06 0.19 0.03 Proteobact. !-proteobact. Pseudomonadales Pseudomonad. Pseudomonas 
OTU308 0.02 0.27 0.18 0.08 0.00 Proteobact. β-proteobact. Burkholderiales Comamonad.   
309900 0.00 0.25 0.03 0.14 0.01 Proteobact. β-proteobact. Burkholderiales    
541859 0.02 0.24 0.00 0.18 0.04 Proteobact. !-proteobact. Pseudomonadales Pseudomonad. Pseudomonas 
833853 0.19 0.23 0.12 0.32 0.18 Proteobact. β-proteobact. Burkholderiales Comamonad.   
336069 0.16 0.23 0.01 0.26 0.49 Proteobact. !-proteobact. Legionellales    
679178 0.00 0.21 0.08 0.11 0.80 Proteobact. δ-proteobact. Myxococcales    
OTU111 0.00 0.18 0.04 0.03 0.02 Proteobact. β-proteobact. Burkholderiales Comamonad.   
731749 0.02 0.18 0.14 0.06 0.00 Proteobact. β-proteobact. Burkholderiales Comamonad.   
OTU1152 0.00 0.17 0.01 0.03 0.00 Proteobact. β-proteobact. Burkholderiales Comamonad.   
OTU760 0.00 0.16 0.01 0.02 0.02 Proteobact. β-proteobact. Burkholderiales Comamonad.   
OTU23 0.01 0.15 0.10 0.03 0.00 Proteobact. β-proteobact. Burkholderiales Comamonad.   
549837 0.00 0.15 0.00 0.07 0.04 Proteobact. !-proteobact. Pseudomonadales Pseudomonad. Pseudomonas 
719367 0.00 0.12 0.02 0.01 0.00 Proteobact. β-proteobact. Burkholderiales Comamonad.  
631674 0.05 0.12 1.09 1.76 1.02 Proteobact. β-proteobact.   
OTU323 0.00 0.11 0.00 0.01 0.00 Proteobact. β-proteobact. Burkholderiales Comamonad.   
320572 0.01 0.11 0.01 0.08 0.11 Proteobact. β-proteobact. Burkholderiales   
4408559 0.01 0.11 0.02 0.01 0.00 Proteobact. β-proteobact. Burkholderiales Comamonad.   
254127 0.05 0.10 0.03 0.13 0.19 Proteobact. α-proteobact. Rickettsiales Rickettsiaceae   
OTU980 0.00 0.10 0.06 0.05 0.01 Proteobact. !-proteobact. Alteromonadales Chromatiaceae Rheinheimera 
OTU754 0.03 0.10 0.09 0.06 0.02 Unassigned     
674057 0.03 0.10 0.03 0.10 0.03 Proteobact. β-proteobact. Burkholderiales Comamonad. Acidovorax 
OTU655 0.01 0.09 0.10 0.03 0.04 Proteobact. β-proteobact. Burkholderiales Comamonad. Acidovorax 
OTU1056 0.07 0.09 0.13 0.12 0.01 Proteobact. α-proteobact. Rhodobacterales 
Rhodobacteracea
e Rhodobacter 
33411 0.03 0.08 0.05 0.00 0.01 Proteobact. β-proteobact. Burkholderiales Comamonad.   
 94 
OTU582 0.00 0.08 0.03 0.00 0.00 Proteobact. α-proteobact. Rickettsiales    
342084 0.00 0.08 0.01 0.00 0.00 Proteobact. β-proteobact. Burkholderiales Comamonad.  
141042 0.01 0.07 0.04 0.01 0.00 Proteobact. β-proteobact. Burkholderiales Comamonad.  
1106617 0.03 0.07 0.02 0.07 0.01 Proteobact. β-proteobact. Burkholderiales   
764682 0.01 0.06 16.82 0.05 0.00 Proteobact. !-proteobact. Pseudomonadales Pseudomonad. Pseudomonas 
OTU1177 0.00 0.06 0.02 0.06 0.04 Proteobact. !-proteobact. Alteromonadales Chromatiaceae Rheinheimera 
587805 0.05 0.06 0.10 0.01 0.00 Proteobact. β-proteobact. Burkholderiales Comamonad.  
OTU1101 0.00 0.06 0.02 0.04 0.00 Proteobact. !-proteobact. Pseudomonadales Pseudomonad.   
60734 0.00 0.05 0.36 0.07 0.04 Bacteroidetes Flavobacteriia Flavobacteriales Flavobacteriaceae Flavobacterium 
OTU1292 0.00 0.04 0.04 0.01 0.02 Proteobact. !-proteobact. Pseudomonadales Pseudomonad. Pseudomonas 
574722 0.01 0.04 0.08 0.04 0.00 Proteobact. β-proteobact. Burkholderiales Comamonad.   
OTU983 0.03 0.04 0.01 0.01 0.01 Proteobact. α-proteobact.    
580078 0.01 0.03 0.10 0.02 0.00 Proteobact. !-proteobact. Alteromonadales Chromatiaceae Rheinheimera 
OTU948 0.03 0.03 0.09 0.01 0.00 Unassigned     
OTU555 0.00 0.03 0.06 0.01 0.00 Proteobact. !-proteobact. Pseudomonadales Pseudomonad. Pseudomonas 
OTU916 0.00 0.03 0.04 0.03 0.00 Bacteroidetes Flavobacteriia Flavobacteriales Flavobacteriaceae Flavobacterium 
OTU1052 0.01 0.03 0.01 0.11 0.45 Proteobact. β-proteobact. Burkholderiales Comamonad.   
4017244 
35.9
9 0.03 0.02 0.03 0.05 Spirochaetes [Leptospirae] [Leptospirales] Leptospiraceae Turneriella 
578606 0.01 0.02 0.12 0.01 0.00 Proteobact. !-proteobact. Pseudomonadales Pseudomonad.  
616184 0.00 0.02 0.09 0.00 0.00 Proteobact. α-proteobact. Sphingomonadales 
Sphingomonadac
eae Sphingomonas 
OTU487 0.00 0.02 0.00 0.34 0.36 Proteobact. β-proteobact. Burkholderiales Comamonad.   
OTU77 0.00 0.02 0.01 0.08 0.03 Proteobact. !-proteobact.   
OTU1091 0.00 0.02 0.00 0.13 0.11 Proteobact. β-proteobact. Burkholderiales   
OTU483 0.01 0.01 0.13 0.03 0.00 Proteobact. !-proteobact. Legionellales Legionellaceae   
40352 0.00 0.01 0.07 0.05 0.02 Bacteroidetes 
Sphingobacteri
ia Sphingobacteriales    
OTU863 0.00 0.01 0.01 0.22 0.22 Proteobact. β-proteobact. Burkholderiales Comamonad. Acidovorax 
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OTU78 0.15 0.01 0.00 0.01 0.00 Bacteroidetes Flavobacteriia Flavobacteriales Flavobacteriaceae Flavobacterium 
143253 0.00 0.01 0.12 0.03 0.00 Proteobact. β-proteobact. Rhodocyclales Rhodocyclaceae   
OTU418 0.01 0.01 0.01 0.03 0.41 Proteobact. β-proteobact. Burkholderiales Comamonad.   
OTU339 0.00 0.00 0.04 0.10 0.24 Proteobact. α-proteobact. Rickettsiales    
1145471 0.00 0.00 0.04 0.91 
13.0
8 Proteobact. β-proteobact. Burkholderiales Comamonad.   
OTU674 0.45 0.00 0.00 0.00 0.01 Spirochaetes Leptospirae Leptospirales Leptospiraceae Turneriella 
1108726 0.00 0.00 0.08 0.33 0.34 Proteobact. β-proteobact. Burkholderiales Comamonad. Rubrivivax 
538346 0.00 0.00 0.06 0.01 
28.1
2 Bacteroidetes Saprospirae Saprospirales Saprospiraceae   
1116384 0.18 0.00 0.02 0.02 0.01 Proteobact. β-proteobact. Burkholderiales Comamonad.   
OTU481 0.00 0.00 0.00 0.00 2.27 Proteobact. !-proteobact. Legionellales Legionellaceae   
581640 0.00 0.00 0.01 0.01 0.13 Proteobact. β-proteobact. Burkholderiales Comamonad.   
OTU150 0.00 0.00 0.00 0.00 1.45 Proteobact. α-proteobact. Rhizobiales   
OTU1132 0.00 0.00 0.00 0.00 1.17 Unassigned     
4306966 0.00 0.00 0.00 0.00 1.15 Proteobact. α-proteobact. Rhizobiales 
Hyphomicrobiace
ae 
Hyphomicrobiu
m 
366100 0.00 0.00 0.00 0.00 0.99 TM6 SJA-4     
590266 0.00 0.00 0.00 0.00 0.77 Proteobact. α-proteobact. Rhodobacterales 
Hyphomonadacea
e   
511723 0.00 0.00 0.00 0.00 0.74 Proteobact. β-proteobact. Rhodocyclales Rhodocyclaceae  
812595 0.00 0.00 0.00 0.00 0.55 Proteobact. δ-proteobact. Myxococcales    
OTU875 0.00 0.00 0.00 0.00 0.39 Unassigned     
22253 0.00 0.00 0.00 0.00 0.35 Proteobact. !-proteobact. Legionellales Coxiellaceae   
566212 0.00 0.00 0.00 0.00 0.29 Proteobact. α-proteobact. Rhizobiales 
Hyphomicrobiace
ae 
Hyphomicrobiu
m 
4333746 0.00 0.00 0.00 0.00 0.22 Proteobact. α-proteobact. Rhodobacterales 
Rhodobacteracea
e Rhodobacter 
702015 0.00 0.00 0.00 0.00 0.18 Bacteroidetes 
Sphingobacteri
ia Sphingobacteriales    
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679997 0.00 0.00 0.00 0.00 0.18 Proteobact. α-proteobact. Rhodospirillales Rhodospirillaceae   
665228 0.00 0.00 0.00 0.00 0.17 Bacteroidetes Saprospirae Saprospirales Chitinophagaceae   
822806 0.00 0.00 0.00 0.00 0.13 Chloroflexi Anaerolineae SBR1031 A4b   
3995177 0.00 0.00 0.00 0.00 0.06 Proteobact. α-proteobact. Rhizobiales 
Hyphomicrobiace
ae 
Hyphomicrobiu
m 
719608 0.00 0.00 0.00 0.00 0.05 Proteobact. α-proteobact. Rhizobiales Rhizobiaceae  
735795 0.04 0.00 0.00 0.00 0.03 Proteobact. α-proteobact. Rhizobiales    
4385991 0.00 0.00 0.00 0.00 0.02 Proteobact. α-proteobact. Rhizobiales    
OTU230 0.00 0.00 0.00 0.00 0.02 Proteobact. δ-proteobact. Bdellovibrionales 
Bdellovibrionacea
e Bdellovibrio 
4312803 0.00 0.00 0.00 0.00 0.01 Proteobact. α-proteobact. Rhizobiales 
Hyphomicrobiace
ae Devosia 
OTU343 0.00 0.00 0.00 0.00 0.01 Proteobact. α-proteobact. Rhizobiales 
Hyphomicrobiace
ae 
Hyphomicrobiu
m 
4323379 0.00 0.00 0.00 0.00 0.22 Proteobact. β-proteobact. Burkholderiales Comamonad.  
672144 0.00 0.00 0.00 0.00 0.04 Proteobact. β-proteobact. Burkholderiales Comamonad.  
1088305 0.11 0.00 0.00 0.00 0.00 
Actinobacteri
a Actinobacteria Actinomycetales 
Corynebacteriace
ae 
Corynebacteriu
m 
OTU420 0.00 0.00 0.00 0.01 0.29 Proteobact. β-proteobact. Burkholderiales Comamonad.   
494367 0.00 0.00 0.00 0.01 0.00 Proteobact. α-proteobact. Rhizobiales Rhizobiaceae Agrobacterium 
553551 0.00 0.00 0.00 0.03 0.25 Proteobact. β-proteobact. Burkholderiales Comamonad.   
Supplementary Table 3. Overview of annotation results. The significantly increased mass 
traces from the microbe-containing versus germ-free polyps (FC > 1.5, p < 0.05) were 
searched for across the mass spectra of the microbial species and the active extracts. Six of 
these mass traces were present in all three datasets, and four could be annotated. 
mz Datasets Adducts Formulae Cmpds 
349.1423 All datasets M+Cl C16H26O6 3 
363.1216 All datasets M+Cl C16H24O7 8 
363.158 All datasets M-H C16H29O7P 1 
365.1373 All datasets M+Cl C16H26O7 16 
347.1267 All datasets N/A N/A 0 
361.1423 All datasets N/A N/A 0 
343.1318 Hydra+Extracts M+Cl C17H24O5 5 
361.1504 Hydra+Extracts M+FA-H C15H24O7 2 
369.1685 Hydra+Extracts M+Cl, M-H C16H30O7, 
C20H27NaO5 
6 
172.0979 Microbe+Extracts M+FA-H, M-H C7H13NO, C8H15NO3 14 
186.1136 Microbe+Extracts M+FA-H, M-H C8H15NO, C9H17NO3 14 
187.0976 Microbe+Extracts M+FA-H, M-H C8H14O2, C9H16O4 71 
200.1292 Microbe+Extracts M+FA-H, M-H C10H19NO3, C9H17NO 8 
201.0768 Microbe+Extracts M+FA-H, M-H C8H12O3, C9H14O5 5 
201.1132 Microbe+Extracts M+FA-H, M-H C10H18O4, C9H16O2 63 
202.1085 Microbe+Extracts M+FA-H, M-H C8H15NO2, C9H17NO4 11 
207.0121 Microbe+Extracts M-H C10H8O3S 2 
214.1085 Microbe+Extracts M+FA-H, M-H C10H17NO4, 
C9H15NO2 
54 
214.1449 Microbe+Extracts M+FA-H, M-H C10H19NO, 
C11H21NO3 
4 
215.0328 Microbe+Extracts M+Cl, M-H C5H13O7P, C6H12O6 60 
215.0925 Microbe+Extracts M+FA-H C9H14O3 4 
231.0874 Microbe+Extracts M+FA-H, M-H C10H16O6, C9H14O4 4 
239.0804 Microbe+Extracts M+Cl C8H16N2O4 10 
239.1289 Microbe+Extracts M+FA-H C12H18O2 26 
240.0644 Microbe+Extracts M+Cl C8H15NO5 5 
240.1008 Microbe+Extracts M+Cl C9H19NO4 1 
241.1081 Microbe+Extracts M+FA-H C11H16O3 6 
242.1762 Microbe+Extracts M+FA-H, M-H C12H23NO, 
C13H25NO3 
2 
243.0641 Microbe+Extracts M+Cl C8H16O6 2 
243.1238 Microbe+Extracts M-H C12H20O5 1 
243.1602 Microbe+Extracts M+FA-H, M-H C12H22O2, C13H24O4 71 
250.0932 Microbe+Extracts M+FA-H, M-H C8H15NO5, C9H17NO7 8 
253.1445 Microbe+Extracts M+FA-H, M-H C13H20O2, C14H22O4 18 
256.0593 Microbe+Extracts M+Cl, M-H C7H16NO7P, 
C8H15NO6 
20 
257.1031 Microbe+Extracts M+FA-H, M-H C11H16O4, C12H18O6 3 
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257.1394 Microbe+Extracts M+FA-H C12H20O3 18 
259.1187 Microbe+Extracts M+FA-H, M-H C11H18O4, C12H20O6 5 
261.1344 Microbe+Extracts M+FA-H, M-H C11H20O4, C12H22O6 4 
262.0932 Microbe+Extracts M-H C10H17NO7 1 
263.1168 Microbe+Extracts M+Cl C11H20N2O3 7 
268.0957 Microbe+Extracts M+Cl C10H19NO5 1 
269.1312 Microbe+Extracts M+Cl C15H22O2 78 
269.1394 Microbe+Extracts M+FA-H C13H20O3 14 
271.1187 Microbe+Extracts M+FA-H C12H18O4 7 
273.098 Microbe+Extracts M+FA-H, M-H C11H16O5, C12H18O7 3 
273.1344 Microbe+Extracts M+FA-H C12H20O4 7 
277.1445 Microbe+Extracts M+FA-H, M-H C15H20O2, C16H22O4 58 
283.1551 Microbe+Extracts M+FA-H, M-H C14H22O3, C15H24O5 9 
285.2071 Microbe+Extracts M+FA-H, M-H C15H28O2, C16H30O4 52 
287.15 Microbe+Extracts M+FA-H C13H22O4 2 
289.1212 Microbe+Extracts M+Cl C14H22O4 2 
291.2096 Microbe+Extracts M+Cl C16H32O2 32 
292.1038 Microbe+Extracts M+FA-H, M-H C10H17NO6, 
C11H19NO8 
9 
293.1792 Microbe+Extracts M-H C14H30O4S 1 
295.1398 Microbe+Extracts M+FA-H C11H22O6 1 
298.0699 Microbe+Extracts M+Cl, M-H C10H17NO7, 
C9H18NO8P 
3 
299.15 Microbe+Extracts M+FA-H C14H22O4 2 
301.1293 Microbe+Extracts M+FA-H, M-H C13H20O5, C14H22O7 3 
301.1657 Microbe+Extracts M+FA-H, M-H C14H24O4, C15H26O6 3 
302.1245 Microbe+Extracts M-H C13H21NO7 1 
302.1609 Microbe+Extracts M+FA-H, M-H C13H23NO4, 
C14H25NO6 
2 
303.1369 Microbe+Extracts M+Cl C15H24O4 9 
307.2045 Microbe+Extracts M+Cl C16H32O3 29 
309.1014 Microbe+Extracts M+Cl, M+FA-H C11H20O5S, 
C15H18N2O3 
4 
309.1707 Microbe+Extracts M+FA-H, M-H C16H24O3, C17H26O5 9 
309.1741 Microbe+Extracts M+Cl C17H26N2O 5 
311.2228 Microbe+Extracts M+FA-H, M-H C17H30O2, C18H32O4 69 
313.1576 Microbe+Extracts M+Cl C17H26O3 7 
313.2384 Microbe+Extracts M+FA-H, M-H C17H32O2, C18H34O4 103 
315.1813 Microbe+Extracts M+FA-H, M-H C15H26O4, C16H28O6 9 
319.2409 Microbe+Extracts M+Cl C18H36O2 27 
320.1998 Microbe+Extracts M+Cl C16H31NO3 1 
322.2154 Microbe+Extracts M+Cl C16H33NO3 2 
323.1267 Microbe+Extracts M-H C13H25O7P 1 
328.213 Microbe+Extracts M+FA-H, M-H C16H29NO3, 
C17H31NO5 
4 
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329.1525 Microbe+Extracts M+Cl C17H26O4 7 
333.111 Microbe+Extracts M+Cl C15H22O6 5 
335.1631 Microbe+Extracts M+Cl C16H28O5 3 
336.1583 Microbe+Extracts M+Cl C15H27NO5 1 
337.1787 Microbe+Extracts M+Cl C16H30O5 2 
341.1372 Microbe+Extracts M+Cl C14H26O7 1 
343.1682 Microbe+Extracts M+Cl C18H28O4 29 
343.2126 Microbe+Extracts M+FA-H, M-H C17H30O4, C18H32O6 136 
344.1998 Microbe+Extracts M+Cl C18H31NO3 1 
345.1474 Microbe+Extracts M+Cl C17H26O5 4 
345.1838 Microbe+Extracts M+Cl C18H30O4 29 
346.2154 Microbe+Extracts M+Cl C18H33NO3 1 
347.1348 Microbe+Extracts M+FA-H, M-H C14H22O7, C15H24O9 2 
348.13 Microbe+Extracts M+FA-H C13H21NO7 1 
348.2311 Microbe+Extracts M+Cl C18H35NO3 2 
358.2235 Microbe+Extracts M+FA-H C17H31NO4 3 
359.1631 Microbe+Extracts M+Cl C18H28O5 5 
360.1947 Microbe+Extracts M+Cl C18H31NO4 10 
360.2392 Microbe+Extracts M+FA-H C17H33NO4 3 
361.1787 Microbe+Extracts M+Cl C18H30O5 42 
362.2104 Microbe+Extracts M+Cl C18H33NO4 4 
363.1944 Microbe+Extracts M+Cl C18H32O5 32 
364.226 Microbe+Extracts M+Cl, M-H C17H36NO5P, 
C18H35NO4 
3 
365.1737 Microbe+Extracts M-H C21H25F3O2 1 
365.21 Microbe+Extracts M+Cl C18H34O5 17 
366.2417 Microbe+Extracts M-H C17H38NO5P 1 
367.1529 Microbe+Extracts M+Cl, M-H C15H29O8P, C16H28O7 18 
367.1893 Microbe+Extracts M-H C16H33O7P 3 
375.158 Microbe+Extracts M+Cl C18H28O6 3 
377.0856 Microbe+Extracts M+Cl C12H22O11 60 
377.1737 Microbe+Extracts M+Cl C18H30O6 5 
379.1893 Microbe+Extracts M+Cl, M-H C17H33O7P, C18H32O6 135 
380.2209 Microbe+Extracts M+Cl, M+FA-H C18H35NO5, 
C20H31O4 
3 
381.1685 Microbe+Extracts M+Cl C17H30O7 1 
389.1736 Microbe+Extracts M+Cl, M-H-
H2O 
C19H30O6, 
C25H29FO2Si 
3 
389.21 Microbe+Extracts M+Cl C20H34O5 108 
391.1893 Microbe+Extracts M+Cl C19H32O6 15 
393.2049 Microbe+Extracts M-H C18H35O7P 1 
394.2002 Microbe+Extracts M+FA-H C20H29O5 1 
396.2158 Microbe+Extracts M+FA-H, M-H C16H34NO5P, 
C17H36NO7P, 
C20H31O5 
6 
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405.1897 Microbe+Extracts M+Cl C16H34O9 1 
409.1998 Microbe+Extracts M+Cl C19H34O7 1 
411.1791 Microbe+Extracts M+Cl, M+FA-H C18H32O8, 
C21H25F3O2 
2 
419.2206 Microbe+Extracts M-H C20H37O7P 1 
423.2155 Microbe+Extracts M+Cl, M-H C19H37O8P, C20H36O7 2 
431.2206 Microbe+Extracts M+Cl, M-H C21H37O7P, C22H36O6 7 
441.2527 Microbe+Extracts M+Cl C23H38N2O4 1 
473.2826 Microbe+Extracts M+Cl C29H42O3 2 
479.1478 Microbe+Extracts M+Cl, M+FA-H, 
M-H 
C23H27ClO6, 
C24H28O8, 
C24H29ClO8 
3 
265.1479 Microbe+Extracts N/A N/A 0 
287.1136 Microbe+Extracts N/A N/A 0 
293.1161 Microbe+Extracts N/A N/A 0 
297.153 Microbe+Extracts N/A N/A 0 
305.1161 Microbe+Extracts N/A N/A 0 
307.1318 Microbe+Extracts N/A N/A 0 
309.111 Microbe+Extracts N/A N/A 0 
321.111 Microbe+Extracts N/A N/A 0 
321.1474 Microbe+Extracts N/A N/A 0 
321.2105 Microbe+Extracts N/A N/A 0 
335.1267 Microbe+Extracts N/A N/A 0 
337.2054 Microbe+Extracts N/A N/A 0 
339.1216 Microbe+Extracts N/A N/A 0 
339.158 Microbe+Extracts N/A N/A 0 
339.1999 Microbe+Extracts N/A N/A 0 
349.106 Microbe+Extracts N/A N/A 0 
353.2003 Microbe+Extracts N/A N/A 0 
355.2239 Microbe+Extracts N/A N/A 0 
367.2441 Microbe+Extracts N/A N/A 0 
371.2552 Microbe+Extracts N/A N/A 0 
378.2053 Microbe+Extracts N/A N/A 0 
379.1529 Microbe+Extracts N/A N/A 0 
381.2316 Microbe+Extracts N/A N/A 0 
381.2597 Microbe+Extracts N/A N/A 0 
393.1686 Microbe+Extracts N/A N/A 0 
395.1842 Microbe+Extracts N/A N/A 0 
395.2754 Microbe+Extracts N/A N/A 0 
407.2318 Microbe+Extracts N/A N/A 0 
449.2159 Microbe+Extracts N/A N/A 0 
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Supplementary Table 4. Putative annotations for the six mass traces that were high in 
control animals, and present in microbial cultures, as well as the original bioactive extracts. 
m/z Adduct Name Formula 
365.1373 M+Cl Picrocrocin C16H26O7 
365.1373 M+Cl 8-Epiiridodial glucoside C16H26O7 
365.1373 M+Cl Iridodial glucoside C16H26O7 
365.1373 M+Cl Tetranor-PGFM C16H26O7 
365.1373 M+Cl (3b,4b,5b)-4,5-Epoxy-p-menth-1-en-3-ol 3-
glucoside 
C16H26O7 
365.1373 M+Cl (1R,4R,5S)-5-Hydroxyfenchone glucoside C16H26O7 
365.1373 M+Cl (4S,6R)-p-Mentha-1,8-diene-6,7-diol 7-glucoside C16H26O7 
365.1373 M+Cl (1R,4S,6R)-6-Hydroxyfenchone glucoside C16H26O7 
365.1373 M+Cl 6-Hydroxy-2-bornanone glucoside C16H26O7 
365.1373 M+Cl (1S,4R)-10-Hydroxyfenchone glucoside C16H26O7 
365.1373 M+Cl Portuloside A C16H26O7 
365.1373 M+Cl Epijasminoside A C16H26O7 
365.1373 M+Cl Schizonepetoside C C16H26O7 
365.1373 M+Cl Schizonepetoside D C16H26O7 
365.1373 M+Cl Schizonepetoside B C16H26O7 
365.1373 M+Cl Schizonepetoside A C16H26O7 
347.1267 N/A No compounds found N/A 
361.1423 N/A No compounds found  N/A 
349.1423 M+Cl (-)-trans-Carveol glucoside C16H26O6 
349.1423 M+Cl Perilloside A C16H26O6 
349.1423 M+Cl (+)-trans-Carveol glucoside C16H26O6 
363.1216 M+Cl Tetranor-PGDM C16H24O7 
363.1216 M+Cl Tetranor-PGEM C16H24O7 
363.1216 M+Cl Prostaglandin M C16H24O7 
363.1216 M+Cl 3-Hydroxy-4-isopropylbenzyl alcohol 3-glucoside C16H24O7 
363.1216 M+Cl Cymorcin monoglucoside C16H24O7 
363.1216 M+Cl Perilloside B C16H24O7 
363.1216 M+Cl PGDM C16H24O7 
363.1216 M+Cl Rhododendrin C16H24O7 
363.158 M-H (10S)-Juvenile hormone III diol phosphate C16H29O7P 
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Supplementary Table 5. List of significantly different mass traces identified in the 5-microbe 
extracts compared to the microbe-free extracts. FC = Fold change. 
Compound Annotation or m/z FC P value 
159.06522 45.196 0.00219 
241.06836 42.112 0.011505 
377.21485 30.427 0.0039034 
159.03291 29.342 0.038282 
218.92487 18.489 0.037108 
203.07658 18.062 0.030476 
61.06477 16.211 0.018825 
157.08592 14.799 0.0011041 
239.0891 13.297 0.0090042 
127.99582 12.708 0.0004809 
161.06589 12.38 0.026745 
330.04698 11.71 0.0017695 
333.18847 10.826 0.0038577 
121.12234 9.5934 0.045459 
289.16228 9.5409 0.0026088 
358.25928 9.282 0.0061549 
194.96333 9.0915 0.0075706 
311.18306 9.0425 0.020648 
308.22226 8.6565 0.043266 
299.27363 8.519 0.0084894 
255.06412 8.3876 0.02429 
269.09968 8.3333 0.010612 
217.05598 8.1324 0.044387 
94.99051 7.8469 0.0056242 
228.08238 7.7645 0.039843 
335.16038 7.733 0.0016424 
346.02482 7.519 0.040272 
321.18124 7.4887 0.017584 
365.19375 7.4079 0.028266 
421.24121 7.3514 0.023126 
103.11172 7.2749 0.03361 
95.04914 7.2699 0.03106 
121.08595 7.2302 0.0060323 
372.19213 6.9542 0.0076808 
153.12739 6.7353 0.021155 
269.14958 6.7125 0.0019956 
171.13796 6.6987 0.048703 
287.27349 6.6612 0.021473 
331.17272 6.3317 0.037744 
191.17946 6.1279 0.022193 
161.01222 5.8939 0.045928 
 103 
206.60974 5.8622 0.02454 
305.14963 5.7644 0.032026 
312.16699 5.7065 0.035063 
202.18026 5.4756 0.027044 
399.26179 5.4685 0.043563 
449.23581 5.1363 0.031483 
180.89451 5.0748 0.02421 
151.14812 5.0012 0.013689 
247.13058 4.9666 0.043288 
177.16381 4.9459 0.021327 
209.19011 4.8284 0.022399 
79.07534 4.7616 0.0085236 
327.26598 4.7219 0.020177 
350.71069 4.6933 0.0046592 
231.11296 4.6081 0.017219 
267.00288 4.5913 0.0031632 
226.0753 4.5499 0.042782 
273.16738 4.5011 0.0078083 
215.01639 4.4521 0.0054217 
256.19187 4.3878 0.0093341 
259.16534 4.3138 0.034084 
303.1414 4.3132 0.010888 
149.02334 4.2935 0.0158 
254.21156 4.219 0.048314 
311.19657 4.2139 0.02333 
128.10701 4.1754 0.030996 
245.13599 4.139 0.0047686 
481.26181 4.0426 0.029492 
215.20069 4.0352 0.017745 
184.13327 3.872 0.044534 
159.13795 3.8682 0.039852 
198.14895 3.8409 0.02997 
163.14817 3.8131 0.047985 
263.23702 3.738 0.04292 
236.97404 3.6686 0.0071499 
231.21088 3.4986 0.033481 
437.23567 3.4788 0.045879 
255.2068 3.4687 0.049746 
259.2422 3.4195 0.030844 
219.21088 3.2045 0.0059876 
251.23708 2.9925 0.024608 
212.16468 2.9718 0.0099306 
223.20578 2.953 0.025546 
233.22648 2.934 0.010763 
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123.11683 2.7659 0.017555 
226.18026 2.7331 0.006592 
343.20104 2.6851 0.037737 
246.20648 2.6503 0.0079126 
109.10119 2.5494 0.0076535 
81.06986 2.5238 0.006989 
125.09611 2.5114 0.045664 
471.30661 2.5094 0.0098604 
83.08551 2.48 0.00499 
97.06478 2.4399 0.0022341 
247.24212 2.4379 0.0023224 
243.12034 2.4301 0.037638 
257.18613 2.4039 0.01059 
84.08076 2.392 0.0057853 
433.38142 2.3767 0.038496 
191.01671 2.3645 0.046831 
95.08553 2.317 0.0077261 
125.13249 2.3129 0.021972 
73.06477 2.3055 0.043272 
85.10117 2.2842 0.0015546 
137.1325 2.2831 0.012817 
Isovalerate 2.2496 0.0049257 
367.2456 2.2029 0.043019 
129.05462 2.151 0.0053057 
71.08552 2.1469 0.011131 
275.11012 2.1383 0.0064594 
111.11684 2.1329 0.0099219 
474.23464 2.1216 0.011877 
393.20987 2.0543 0.038099 
256.26351 2.0368 0.0084104 
97.10118 2.0263 0.0009323 
349.18343 1.688 0.020825 
221.07437 1.6573 0.04289 
147.06521 1.6473 0.0044027 
195.06285 1.6231 0.032849 
183.06283 1.5611 0.0049553 
gamma-Aminobutyric acid 1.5475 0.019205 
427.28082 1.5169 0.035667 
329.19333 0.53523 0.046665 
425.21463 0.51058 0.03791 
415.2543 0.46092 0.04131 
296.19682 0.40483 0.025747 
132.10192 0.35666 0.010314 
199.14418 0.34509 0.033525 
 105 
273.11839 0.321 0.038474 
104.9923 0.30399 0.036902 
385.22234 0.29175 0.038335 
357.15426 0.27089 0.030332 
408.24679 0.2637 0.0054796 
254.16473 0.26293 0.016037 
353.2298 0.23991 0.042711 
181.0948 0.23408 0.018045 
453.24523 0.22527 0.03479 
422.26207 0.22433 0.018687 
269.09443 0.2118 0.024439 
389.25094 0.20893 0.0015856 
289.09229 0.20068 0.030814 
450.29338 0.1942 0.021207 
279.10286 0.19106 0.0050733 
227.17551 0.19085 0.0029881 
210.11791 0.18845 0.026753 
327.25463 0.17848 0.039168 
419.21328 0.17497 0.046248 
86.09641 0.17488 0.044536 
263.15304 0.17216 0.0029298 
361.20988 0.16751 0.026841 
129.10225 0.16329 0.034689 
213.15985 0.16285 0.0039114 
440.25048 0.16157 0.017233 
147.11279 0.15214 0.012095 
323.19357 0.15103 0.043893 
392.25436 0.13941 0.0083151 
L-Proline/2-Pyrrolidinecarboxylic acid 0.13837 0.0044961 
439.26508 0.12996 0.019012 
186.99546 0.12454 0.023306 
433.22819 0.11675 0.047504 
437.25065 0.10834 0.0040371 
361.24657 0.10301 0.0018655 
348.17406 0.1011 0.0094894 
120.0808 0.094588 0.029008 
185.16484 0.091051 0.030076 
314.20741 0.089273 4.36E-05 
446.24343 0.088624 0.0067828 
371.22894 0.076292 0.0023423 
288.19193 0.076028 0.0092515 
269.16085 0.072566 0.0095935 
143.11791 0.071079 0.0079823 
166.08626 0.061151 0.0080638 
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215.13912 0.055545 0.009785 
394.23365 0.054866 0.0011711 
338.18391 0.053717 0.0022466 
199.18054 0.051347 0.016673 
228.1707 0.042135 0.0037189 
233.16494 0.037195 0.014852 
338.18225 0.03695 0.0017223 
229.15478 0.036038 0.0020339 
213.12349 0.031589 0.0070103 
263.13919 0.026372 0.0014493 
286.17625 0.026042 0.0015231 
245.18609 0.023201 0.0026526 
329.14965 0.015588 0.0057941 
326.20921 0.014896 1.49E-05 
205.09722 0.013446 0.0057336 
326.20755 0.013346 0.00014604 
136.06177 0.010713 0.0021802 
294.18132 0.0087617 0.00050776 
260.19703 0.0067451 0.00028824 
279.17052 0.0055888 0.00021284 
342.2391 0.0019176 2.55E-05 
328.22341 0.0014118 1.39E-05 
288.20324 0.00098907 6.74E-05 
Adenosine 0.00030202 8.28E-05 
 
Supplementary Table 6. Percent abundance of the OTUs present in the native microbiota extract with manual annotation of the main colonizing 
species of Hydra. The percent abundance (%) does not reflect the abundances on the polyps as the bacteria have very different growth rates in 
vivo compared to in vivo. 
OTU ID % Phylum Class Order Family Genus 
OTU17 57.23 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae  
750018 11.04 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae Pseudomonas 
OTU2 (Undibacterium) 8.31 Proteobacteria Betaproteobacteria Burkholderiales Oxalobacteraceae   
750411 (Curvibacter) 4.29 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
839235 2.85 Proteobacteria Gammaproteobacteria Aeromonadales Aeromonadaceae  
545507 (Acidovorax) 1.65 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae Acidovorax 
587804 1.22 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae  
OTU6 1.18 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae   
33410 0.99 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
OTU4 0.82 Proteobacteria Betaproteobacteria Burkholderiales Oxalobacteraceae   
1136510 0.78 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
OTU1066 0.66 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae  
256215 0.58 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae Pseudomonas 
541859 0.55 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae Pseudomonas 
OTU6664 0.43 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae Pseudomonas 
OTU6919 0.52 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae  
OTU7933 0.40 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae Acidovorax 
OTU20 0.36 Proteobacteria Gammaproteobacteria Aeromonadales Aeromonadaceae   
764682 0.35 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae Pseudomonas 
578606 0.36 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae Pseudomonas 
837574 0.29 Proteobacteria Gammaproteobacteria Aeromonadales Aeromonadaceae  
OTU16015 0.35 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae  
OTU14 0.30 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
OTU16816 0.27 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae  
731748 0.28 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
141316 0.24 Proteobacteria Betaproteobacteria Burkholderiales   
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OTU5768 0.25 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
OTU15407 0.23 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
4391034 (Pelomonas) 0.22 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
OTU597 0.24 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
OTU5533 0.25 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae Pseudomonas 
549837 0.20 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae Pseudomonas 
OTU11809 0.20 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae Pseudomonas 
OTU8046 0.16 Unassigned     
OTU6895 0.14 Proteobacteria Gammaproteobacteria Aeromonadales Aeromonadaceae   
OTU5045 0.16 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae Acidovorax 
574721 0.16 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
OTU7613 0.13 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
797572 0.10 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
833853 0.10 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
OTU16676 0.08 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae  
336824 0.09 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
OTU12776 0.07 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
OTU13535 0.07 Proteobacteria Gammaproteobacteria Aeromonadales Aeromonadaceae  
141042 0.06 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae  
4408559 0.07 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
OTU14782 0.05 Proteobacteria Betaproteobacteria Burkholderiales   
513078 0.04 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae Pseudomonas 
OTU5866 0.04 Proteobacteria Gammaproteobacteria Aeromonadales Aeromonadaceae   
OTU11843 0.05 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae  
OTU14860 0.04 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae Pseudomonas 
OTU4254 0.04 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae  
OTU11087 0.04 Proteobacteria Betaproteobacteria Burkholderiales Oxalobacteraceae   
OTU1278 0.04 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
OTU10168 0.04 Proteobacteria Gammaproteobacteria Pseudomonadales Pseudomonadaceae Pseudomonas 
719367 0.04 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae  
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354682 0.04 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
OTU16170 0.04 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae Rhodoferax 
OTU2749 0.03 Proteobacteria Betaproteobacteria Burkholderiales   
2742255 0.03 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
674815 0.03 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
OTU10046 0.03 Proteobacteria Gammaproteobacteria    
OTU13513 0.03 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae  
OTU2254 0.03 Proteobacteria Betaproteobacteria Burkholderiales Comamonadaceae   
OTU8617 0.03 Proteobacteria Gammaproteobacteria Aeromonadales Aeromonadaceae   
 
